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A. Author's prefac,: 
When I came to the U.S.A., I received training as an 
anesthesiologist and later was employed in this capacity. 
For a research-minded anesthesiologist, two avenues of in-
vestigation seemed natural; either research on physiology 
and pharmacology of respiration or research on the problem 
of neuromyal transmission. 
Many anesthesiologists have done work on the nerve-
muscle junction and contributed not only to applied pharma-
cology of muscle relaxants, but also to the understanding of 
the mechanisms of neuromyal cholinergic transmission. It 
should suffice to mention such anesthesiologists and authors 
of many research papers and important texts as F. Foldes, V. 
Collins, R. D. Dripps, H. C. Churchill-Davidson. My special 
interest in the neuromyal junction was aroused by the reading 
of their stimulating publications as well as by the baffling 
and protean behavior of the nerve-muscle transmission. No 
" one who practices anesthesia oould help but be challenged and 
mystified by the variable sensitivity and the qualitative 
change of the response of the endplate to neuromyal agents. 
Moreover, we deal here with a very basic physiological mech-
anism _ that of cholinergic transmission. Altogether, the 
temptation to study the versatility of this transmission at 
the neuromyal site cannot be easily resisted. This explains 
why, along with anesthesiologists, many prominent neurophysio-
logists and neuropharmacologists either have made the neuro-
myal junction the subj ect of tneir main iJl~eoccupation, as did 
B. Katz, P. Fatt, G. L. Brown, S. W. Kuffler, S. Thesleff, 
E. Zaimis, or at least attacked this subject at one time or 
another, as exemplified by J. C. Eccles, D. Bovet, G. B. 
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Koelle, K. R. W. Unna, J. Hoppe, and others. 
When, therefore, the chance was offered to me to be trained 
in the methodology of studying neuromyal transmission by Dr. 
K. Koketsu and to carry out research for a Ph.D. in this area 
under Dr. A. G. Karczmar, I could not but embrace this chance. 
2. 
B. Iptroduction 
I. PhYsiOlogy of the neuromyal ,iunctio~. 
1. Historical developments leading to the modern 
concepts of neuromyal physiology. 
Before the latter half of the nineteenth century it was 
assumed that a continuity exists between nerve and muscle (cf. 
Brazier, 1959). The muscle was supposed to be activated by a 
nervous fluid, possibly having properties of Newtonls ether, 
which could fill the muscle and provide its tension and rigi-
dity. 
In 1862 Kuehne (cf. also Kuehne, .1888) noted histological 
differences between skeletal muscle and its innervation. He 
suggested that the action current of the nerve, discovered pre-
viously by Du Bois-Reymond (1848, 1849). invaded the muscle 
trans-and caused it to contract. Du Bois-Reymond noticed a 
bolt h 0 \l.Ah 
mission delay at the neuromyal junotion;Aat first he 
/\ l~tet 
considered that it may be due to chemical influences, he be-
lieved that electrical fields of a nerve-muscle 




The importance of the junction was established by the 
researches of Claud& Bernard (1857), which indicated that 
curare acts at a peripheral site on the motor nerve. Subse-
quently Langley (1905, 1907) showed that nicotine can act, 
upon denervacion and motor nerve degeneration, at restricted 
sites vf the muscle fiber. 
At the turn of the century the concept of the chemical 
nature of neuromyal transmission was elaborated by Elliott 
(1905), Dale (cf. his Harvey Lecture, 1937), and Loewi (1921). 
Their work dealt ~rincipally with smooth and cardiac muscle. 
The thought that transmission at the parasympathetic nerve 
endings is cholinergic in nature, originated from Dixon's (1907) 
suggestion that the transmitter may be muscarine, an alkaloid 
related to choline. Subsequently, acetylcholine (ACh) was im-
plicated as a transmitter substance (Hunt and Taveau, 1906; 
Dale, 1914; Loewi, o.c.) at parasympathetic nerves. Finally, 
Dale and his associates (cf. Dale, Feldberg and VOL~; 1936) 
showed that motor nerve terminal releases upon stimUlation a 
pharmacologically active substance, later identified as ACh. 
This classical period of the studies of cholinergic trans-
mission and of the neuromyal junction terminated with the stu-
dies of Sir Lindor Brown (1937,and with Dale, Feldberg, and 
Vogt, 1936) in which they showed that "closel! (1) intra-ar-
terial injection of ACh mimics, in both innervated and dener-
vated muscle, the effects of nerve impulse; this was true with 
regard to mechanical and membrane responses of the musle. It 
could be also shown that curare and physostigmine influence 
mechanical and membrane effeQts of injected ACh just as they 
do the responses of the stimulation of the motor nerve. Thus, 
the transmitter rola of ACh at the motor nerve terminal was 
additionally substantiated by the similarity of the effects of 
drugs upon the muscle response to ACh, on one hand, and to motor 
nerve stimUlation on the other. 
Altogether, we can consider that by the 1940's not only 
the neuromyal transmission was proven to be cholinergic in 
nature, but also the importance of the endplate (e.p.), while 
(1) "Close" intra-arterial injection is a pharmacological term. 
In this technique, the agent is injected into the artery as 
close as possible to its presumed site of action. 
originating from the nineteenth century researches of Kuehne 
(o.c.), and Bernard (o.c.), was finally established as an ACh 
receptor. Both these achievements can be attributed mainly to 
the English school of investigators (Brown, Feldberg, Dale, and 
Eccles; cf. EcOl es, Ka-tz; and Kuffler, 1941). 
2. Physiological events at the endplate. 
a. Morphology of the endplate. The work of Cou-
teaux (1947, 19~5) established that "there are three sharply 
defined components of different cellular origin at the junction" 
(Fatt, 1959). The first of these is the terminal apparatus of 
the nerve; the second - the specialized region of muscle surface 
contacted by the nerve endings; the third - a layer of neuroglia, 
which at this site is referred to as teloglia, continuous with 
the Schwann cell envelope of the myelinated fiber. The teloglia 
contributes half the nuclei of the junctional region (the sole 
nuclei), the remainder being the fundamental nuclei in the 
muscle, and acco~panies the nerve terminals as they sink into 
t~e grooves in the muscle fiber surface. Muscle fibers lining 
the groove form infoldings, as seen in the electron microscope 
(Robertson, 1956; Andersson-Cedergreen, 1959). While the 
picture of the junction as described above is generally 
characteristic for all species, there are differences between 
the mammalian and frog ("bush" endplate) junctions, the mamma1iat 
e.p. occupying a smaller site in relation to the muscle, while 
the nerve terminals of the frog endbush cover a wide area of the 
muscle fiber. 
Most recently, an interesting contribution to the anatomy 
of the nerve terminal portion of the junction was offered by 
De Robertis (1958) and confirmed by Andersson-Cedergreen (1959) 
and other investigators. These investigators showed occurrance 
at the terminal nerve endings of small vesicular elements, 
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called synaptic vesicles. Indirect evidence (cf. Del Castillo 
and Katz, 1956a; and Eccles, 1958) suggests that synaptic 
vesicles contain ACh, presumably in the quantal form of 
"packages" (cf. also below). 
b. Cholinesterases and the neuromyal junction. 
It was shown in a series of researches by Nachmansohn and 
his associates (Marnay and Nachmansohn, 1938; Nachmansohn, 1940; 
cf. also Nachmansohn, 1946 and 1959) that cholinesterase (ChE) 
is an enzyme concentrated at the endplate. In terms of the 
kinetics of its action, ChE can account for the almost instant-
aneous hydrolysis of ACh, released ~t the nerve terminals. The 
rapidity of the action of ChE is a pre-requisite, as proposed 
by Nacbmansohn, for functionab111ty of the neuromyal junction. 
The importance of ChEfs for the function of the neuromyal 
junction and of other synapses has been further extended by 
many investigators (for recent review, cf. Koelle, 1961a and b). 
While their specific function will be reviewed more in detail 
in subsequent sections of this introduction, it should be stated 
at present in general terms that chemical transmission may depend 
not only on the presence of a transmitter, but also upon the 
availability of a hydrolytic enzyme (Loevi, 1921, Giarman, 1957). 
In view of this, and particularly because of their role in the 
neuromyal function, the localization of ChE's in the junction 
is important. 
The ChE of the endplate is predominatly acetyl-cholinester-
ase (AChE), located mostly post-synaptically_ Pseudocholines-
terase (butyrylcholinesterase, BuChE) is present in smaller 
quantities (Denz, 1953; Holmstedt, 1957 and 1959). AChE is 
present also at the musculotendinous junctions. Some AChE or 
BuChE is present in the muscle fiber (Becket and Bourne, 1957). 
6. 
It should be stated here that a physiologically and 
functionally important difference between AChE and BuChE is 
that the former is a faster and a more specific enzyme. As 
stated by Nachmansohn (o.c.), this enzyme, rather than BuChE, 
fullfills the criteria of an enzyme capable of terminating 
the actions of ACh. On the other hand, BuChE may be concerned 
with terminating the action of exoesses of aoetyloholine es-
oaping into the blood stream (Koppanyi and Karozmar, 1953). In 
acoordance with this difference between the two ChEws, AChE 
predominates in central and peripheral synapses, and BuChE in 
the blood and in certain barriers surrounding synapses (Volle 
and Koelle, 1961). 
c. Eleotrioal response at the e.p. and at the 
nerve terminal. 
It was shown first by Eooles and O'Connor (1938) and 
Shaetter and Haass (1939) that a non-propagated negative, mono-
phasio potential arises in a curarized, non-contraoting musole. 
This potential, charaoterized by a brief rising phase and a 
slower return to the baseline, is referred to as the endplate 
potential (e.p.p.); it is focused at the nerve endings, and 
magnitude-wise correlated with their density (Ecoles, Katz and 
Kuffler, 1941 and 1942). Upon reduotion of the ooncentration 
of ourare, action potentials of individual fibers appear as 
defleotions superimposed on the e.p.p., till a full, synchronize1 
aotion potential obsoures the e.p.p. oompletely. To the con-
trary. when the concentration of curare is inoreased, the e.p.p. 
becomes reduoed. 
Fatt and Katz (1951) used the intraoellular recording 
technique to study the e.p.p.'s at the individual musole 
fibers as potentials obtained across the fiber membrane at the 
position of insertion of the electrode. By means of this 
technique the frog muscle fiber was found "to have a resting 
membrane potential of above 90 mv (inside negative with respect 
to outside), which is the same in the junctional region as 
elsewhere along the fiber" (Fatt, 1959). In a frog nerve-
muscle preparation, critically curarized to abolish contraction, 
muscle fibers display, in response to nerve stimulation, e.p.p.' 
s ranging from 10 to 40 mv. The e.p.p. is, ill these conditions, 
a transient positive deflection, or reduction of membrane 
potential from its resting level (depolarization). The e.p.p. 
becomes attenuated and slower when measured progressively 
further away from the llerve terminal. 
Threshold depolarization of 40 mv initiates the propagated, 
biphasic action potential. The spike portion of the action 
potential is the positive deflection of membrane potential, in-
dicating depolarization, plus the overshoot or the reversal of 
the membrane potential. The spike at the e.p. differs in cer-
tain features from the spike evoked in the musole fiber by 
direct stimulation. This may be due to the modification of 
the action potential by junotional aotivity. This aotivity 
consistently causea a deviation toward a level near zero mem-
brane potential (Fatt, 1959). On the basis of further biophy-
sical and experimental analysis, Fatt conoluded that "the 
effect of junotional aotivity on the muscle fiber membrane oan 
be represented as the addition of a conductance in a series 
with a fixed emf. This may further be interpreted as the 
creation of a new path for the diffusion of ions across the 
membrane" (0.0.). 
While the above description of the e.p.p. is based on 
investigations of amphibian muscle fibers, it also applies, 
8. 
exoept for oertain numerical and pattern differenoes, to mamma-
lian muscu~ature. The differences are due to a higher oon-
ductanoe of the latter, with a consequent reduotion in eleotric 
time and spaoe constants. 
An important aspect of ACh as the transmitter substanoe 
at the neuromyal junction is, as already stated» its behavior 
when applied to the junctional tissue. Whether applied to the 
whole muscle fiber, or only to the area invaded by the nerve 
endings, ACh depolarizes the junotional region alone (Cowan, 
1936; Kufflar, 1943; Burns and Paton, 1951). This can be de-
monstrated by means ot iontophoretic technique, in which ACh 
is applied by means of brief eleotric pulses from a micropipette. 
In this case, ACh was found to be ineffective along the whole 
musole fiber (Nastuk, 1953; Del Castillo and Katz, 1955a). 
When amphibian musole is exposed in the presence of ChE in-
hibitors to ACh, the concentration of ljlM depolarizes the 
junotional region suffioiently to produce a spike. With lower 
oonoentrations, depolarization is progor-tional to the amount 
of ACh. With higher concentration, depolarization persists 
after a number of spikes, at the time when the neuromyal juncticn 
is not capable of further initiation of spikes. The viewpoint 
that ACh acts on the e.p. alone was recently attacked by Ochs 
at ale (1959), but even more reoent findings of Katz (1959) seem 
to support the original contention that chemical sensitivity 
of the muscle i3 restricted. High sensitivity to ACh extends 
only over very limited regions in the neighborhood of the nerve 
terminal branches; in the frog, the sensitivity decreases or 
disappears already within 10 to 20 ~ from the nerve terminal. 
Recently, Miledi (1960) thought that this region, while limited. 
extends somewhat further. Depolarization occurs only when ACh 
9. 
is applied to the fiber surfaoe; ACh is not effective when re-
leased within the musole fiber. ~he time course of depolari-
zation, while much longer than that of e.p.p., is consistent 
with the reasonable assumption that ACh must diffuse from its 
point of release to the reoeptor some microns away. Finally, 
depolarization elicited by ACh can be demonstrated (Del Ca&til-
10 and Katz, 1955b) to be caused by the same oonductance 
change which oocurs during transmission. 
The appearance, during quiescence of the nerve, of small 
(0.5 my) transient changes of potential (miniature endplate 
potentials, m ••• p.p.), has an interesting bearing on neuromyal 
transmission. The m.e.p.p.'s e~re~ in a small way, the 
characteristios of the e.p.p.'s. they have a similar time 
oourse, are attenuated away from the nerve terminals, and are 
affected like e.p.p.'e by oertain drugs, such as curare and ChE 
inhibitors. The m.e.p.p.'s disappear upon denervation and 
subsequent degeneration of the nerve terminal. This and other 
considerations caused Fait (1959) in partioular to consider 
m.e.p.p.'s as being due to random collisions of the synaptic 
vesicles, already described as probably containing "packages" 
of ACh, with active sites in the nerve terminal membrane; these 
oollisions would lead to release of "quanta" of AOh, and to 
depolarization at restrioted receptor sites. The normal e.p.p., 
or the spike, depends on the other hand, on synohronized re-
lease of a very large number ot "paokages", leading to a oon-
stant spike amplitude. Not neoessarily the same vesioles dis-
oharge per eaoh spike, although their number, per eaoh spike, 
is oonstant. On the other ha.nd, an incomplete disoharge of 
relatively tew vesioles would lead to a reduoed e.p.p., and 
finally to a m.e.p.p. 
10 .. 
Some of the lines of indirect eVidence for this view-
point are as follows; first, withdrawal of calcium reduces the 
size of the e.p.p., till the e.p.p. becomes not much larger 
than the m.e.p.p.; it also fluctuates in size and can become 
intermittent (Boyd and Martin, 1956a and b; Del Castillo and 
Katz, 1954aj Liley, 1956). This is because (Fatt, 1959) the 
e.p.p. reveals itself under these conditions as being composed 
of a variable number of m.e.p.p.t s , the fluctuation being due 
to variation in number of units firing. Seoond, when trains 
of stimuli are used in the frog nerve muscle preparation, the 
second stimulus leads to a larger e.p.p. When the calcium 
concentration is reduced so that the e.p.p. has an amplitude 
corresponding to postulated discharge of a few synaptic ve-
sicles as described before, the response to the second of the 
stimuli is again increased, and, what is most important, the 
fluctuation is reduced. This reduction of fluctuation can be 
due only to an increase in the number of units, or of synaptic 
vesicles, responding (Del Castillo and Katz, 1954b). 
d. Mechanism of neuromyal transmission. 
From various experiments described above, the amount of 
ACh released during a single nerve impulse at a single junction 
has been calculated as 10-18 moles (Emmelin and McIntosh, 1956). 
This figure, after certain corrections are made, corresponds 
well to the minimal quantity of ACh, applied iontophoretically, 
capable of evoking spike upon application to the endplate. 
ACh, released during the single impulse, is presumably 
liberated by concerted breakage of a constant (per each 
impulse) number of synaptic vesicles in the nerve terminals. 
It can be also calculated that ACh will exert its maximal 
effect before diffusing more than 1 f, a 
11. 
distance which agrees with the morphological, electron micro-
scope findings on the separation of the pre- and post-junctio-
nal surfaces. Finally, ACh will remain in effective concen-
tration at the junction for less than 1 ms, and diffusion 
will terminate the first, high intensity transmitter action, 
expressed by the short duration of the rising phase of the 
e.p.p., or of the spike. On the other hand, desoending phase 
of the e.p.p. will depend on factors other than the movement 
of ACh, for instanoe, on the activity of AChE (Fatt, 1959). 
Finally; upon combining with the receptor, ACh alters physical 
properties of the membrane and a new path appears for ionic 
diffusion; in eleotrical terms, an additional conductance 
short circuits existing potential differences. These concepts, 
when considered jOintly with Grundfestfs (1957; 1959) concept 
of electrical non-excitability of perhaps most synapses; lead 
to a picture of the skeletal neuromyal junction as one of the 
most explored, chemically operated synapses. 
II. Pharmacology of the neuromyal junction. 
1. General concepts. 
Certain aspects of pharmacology of the neuromyal junction 
have been already presented, since they form an integral part 
of our concepts of the neuromyal transmission. Conversely, 
certain drug actions can be deduced from the knowledge of the 
physiology of the e.p. Thus, curare and its crystalline d-
isomer, d-tubocurarine (d-Thc), does not by itself affect 
electric properties of the membrane, but prevents ACh from 
combining with the receptor and from exerting the depolarizing 
action. ACh and d-Tbc interact competitively and the e.p.p. 
will be decreased by large concentrations of d-Tbc because 
under these circumstances depolarization will not suffice 
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to produoe the spike and also it will embraoe only relatively 
few receptor units (Bovet, 1951). A number of synthetio sub-
stanoes share the properties of d-Tbc (Bovet, 1951 and 1959; 
Hoppe, 1957). On the other hand, ChE inhibitors, while in-
oapable of affecting the early phase of ACh action, may cause 
ACh acoumulation at the a.p., ACh then becoming oapable of 
displacing d-Tbc (Pelikan et al., 1956). By means of a similar 
mechanism, anti-ChE agents can inorease the amplitude and 
possibly the frequenoy of m.e.p.p. 's, and prolong the e.p.p. 
(Del Castillo and Katz, 1954c); finally, in the presence of 
anti-ChE agents, single motor nerve ~t1mulation will lead to 
repetitive firing rather than to single spike (Nastuk and 
Alexander, 1954. Karczmar and Fudema, 1957; Karczmar, 1961). 
Repetitive firing is acoompanied by the maoroscopically ob-
servable sustained oontraction, indistinguishable from the 
tetanio twitch whioh is normally obtain9d upon repeated dis-
oharge. 
Finally, oertain substanoes whioh resemble ACh, oan de-
polarize the e.p. similarly to the transmitter substanoe. These 
do not have to be choline esters, but must exhibit a cationio. 
usually quaternary head of oertain electron density, the latter 
depending in part on the dimension of the quaternary or related 
radioal (Riker, 1953, Riker et al., 1958). Among the most 
effective depolar1zers are two bisquaternaries, decamethonium 
(010 ) and succinylcholine (SOh; Paton and Zaimis, 1949; Ginzel 
et al., 1951). Anti-ChE agents, presumably because of protec-
tion they afford ACh, can also depolarize (Douglas and Paton, 
1954); this depolarization ca.n oocur only in the presence 
large conoentrations of the anti-OhE agents. 
of 
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It is of interest that certain ~hemical resemblance exists 
between many an ti-ChE agent s, depolarizers i:::wd cU,L'aremimet ics 
(Karczmar, ..L 961; Karczmar et 0,1., 1961). In fact, many neuro-
myally active agents cannot be easily classified from the 
pharmacological viewpoint; they may exhibit predominantly the 
actions chara0teristic for one type of drugs, and, somewhat 
less extensively, those characteristicS for drugs of another 
type. Thus, certain curaremimetics as well as many cholino-
mimetics may have anti-ChE action (Hoppe, o. c. ) . 'rhis, in turn, 
may indicate certain similarities between ~holinergic receptor 
and the ChE or particularly AChE moiety: (Karczmar, 1961; Karcz-
mar et al., o.c.). 
2. Neuromyal blocking agents and their antagonists. 
a. Curare, ammonium ions and anti-ChE agents . 
.Lhe mechanism of action of curare, d-Tbc, and of synthetic 
curaremimetics was discussed when basic properties of the e.p. 
were described (cf. above). As competitive antagonists of ACh, 
these agents can be antagonized by large doses or concentrations 
of ACh and of other depolarizing agents, principally quaternary 
ammonium compounds. Among the latter can be listed the phenyl"" 
trimethylammonium group investigated by Riker, Wescoe and their 
associates (cf. Wescoe et al., 1949, 1950; Riker et al., 1957, 
1959a). Riker (1953) is of the opinion that these compounds 
act as anticurare agents not only by depolarization but also 
because they displace curare from the e.p., thus exposing 
curare to metabolic destruction. This hypothesis of displace-
ment was originally proposed by A. J. Clark (1933). Part of 
Riker's evidence for this concept is as follows. The effective 
dose of curare or d-Tbc, used alone, may produce a Y2 hr. 
blockade (cat data); depolarizing or excitatory action of 
phenyltrimethylammonium compounds, as evidenced by repetitive 
discharges, is, on the other hand, brief. Yet, when d-Tbc is 
antagonized by a trimethylammonium compound, the blockade does 
not recur. 
The effect of anti-ChE agents is, as already indicated, 
similar to that of large doses of ACh. In fact, Unna and his 
associates (Unna et al., 1944; Pelikan, Smith and Unna, 1956) 
could relate anticurare potenoy of a number of anti-ChE agents 
to the enzymio inhibitory potenoy of the latter. However, in 
the oase of at least these anti-ChE agents, whioh possess a 
quaternary cationic head resembling t~at of trimetyl-ammonium 
compounds or of ACh itself, their potency to displaoe d-Tbo 
and also to produoe the depolarization of the e.p. plays also 
a part in their anti-d-Tbc action. Prime examples are Edro -
phonium (Tenailon), and neostigmine (Prostigmine). Perhaps 
among the first investigators to point out the differenoe 
between the action of neostigmine and that of other anti-ChE 
agents were Jacobsohn and Kahlson (1938). For instance 1 
neostigmine but not other anti-ChE agents, oan produoe musole 
twitoh in the cat upon close intra-arterial injeotion, and 
its anti-curare effect is more prompt than that of physostig-
mine or phosphonate anti-ChE agents (Riker, 1953). However, 
whether acting solely by AChE inhibition, or also direotly, 
this group of curare antagonists provokes repetitive firing 
at the e.p., and oauses potentiation of the mechanical res-
ponse of the muscle to indirect stimUlation. 
b. Unstabilizers of motor nerve terminal and 
curare. 
Masland and Wigton (1940) and Eccles et al. (1942) de-
monstrated that upon administration of neostigmine and physo-
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stigmine short trains of repetitive antidromic discharges 
can be made to appear in motor nerve fibers stimulated with 
sir.t.gle or double shocks. More reoently, Riker, Werner and 
their assooiates (Riker et al., 1957, 1959a and 1959b) studied 
a number of oompounds, whioh are substituted trimethylammoniums 
charaoterized particularly by a hydroxy substitution, but also 
by substitutions of larger alkyl groups for the methyls of the 
parent oompound. Riker and Werner stressed their presynaptic, 
motor nerve terminal site of action. It is Riker's opinion 
that these compounds are not anti-ChE agents, that they do not 
depolarize, and that they produoe rep~titive firing and twitch 
potentiation by unstabi11zation of the nerve terminal. Since 
anti-ChE agents, physostigmine and neostigmine, also produce 
antidromic firing, and since oertain trimethylammonium com-
pounds and their analogs (such as Edrophon1um) exhibit anti-
ChE potency (Nastuk et al., o.c.), it cannot be ruled out that 
hydroxy alkyl ammonium agellts may unstabilize the nerve terminal 
because of their anti-ChE action. It would be difficult to 
prove this. Compounds of this struoture would presumably 
inhibit reversibly cholinesterase aotion and this inhibition 
oannot be readily demonstrated ~ vivo (Karozmar, 1961). 
~asaki (1958) used mioroeleotrode methods on the e.p. of a 
cephalopod (these animals are partioularly convenient for this 
type of study), and he measured direotly the pre- and post-
synaptio potentials. It is possible that his method should 
be used to test further the hypothesis of Riker and his 
assooia.tes. 
It should be pointed out tha.t Koelle and his assooiates 
(Koelle, 1961a and b; Volle and Koelle, 1961) post~lated 
reoently that ACh itself can exert a retrograde action at the 
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nerve terminal causing more release of ACh from its storage; 
while Koelle's postulate was derived from data dealing with 
a sympathetic ganglion, it may be extended to the neuromyal 
junction. Altogether, it may well be that some agents, 
whether cholinomimetic or anti-ChE in nature, or, finally, 
methylammonium derivatives, may produce excitatory and anti-
curare effects at the e.p. by virtue of their nerve terminal 
site of aotion. This action may be facilitatory in some, at 
present, undefined way, or it may be due to release of ACh from 
presumably synaptic vesiole. in the nerve terminal. 
c. Aotion of tetraethyl~onium (TEA) and Sodium 
Fluoride (BaF.). 
aecently stovner (1957a, band c f 1958a, b, and c) and 
Koketsu (1958) have studied still another anti-curare substance 
TEA. Stovner (o.c.), studied mostly the effects of TEA upon 
the blookade of neuromyal junction by curaremimetio substanoes. 
Koketsu (0.0.), pointed out that, paradoxioally, TEA blocked 
ACh depolarization very muoh like a ouraremimetio, and yet 
antagonized d-!bc. They sugge.!e4 that, somewhat like hydroxy-
methylammonium oompounds, TEA. acts presynaptically, and possibll 
releases ACh at that site. This interesting suggestion is 
based on indirect information and deserves further evaluation. 
An interesting feature of the aotion of TEA is that its 
main effeot is the augmentation of the a.p.p. While TEA causes 
some prolongation of the a.p.p., it does 80 to a much lesser 
extent than anti-ChE agents (Koketsu, 1958). A chemically 
unrelated compound, HaF, shares these characteristios with 
TEA (Koketsu and Gerard, 1956). These and other features of 
NaF action led these investigators to oonclude that, without 
being an anti-ChE, it sensitizes the e.p. to ACh (0.0.). 
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d. Depolarizing sub8~ano.s. 
Burns and Paton (Burns and Paton, 1951; Paton, 1952) 
compared depolarizing e.p. aotions of AOh and of decamethonium 
(ClO) on the cat graoilis musole. In both oases, depolari-
~ation was oonfined to the e.p., but it was more or less per-
~i8tent only in the case of 010• Depolarization by 010 re-
~embled that by ACh, provided the musole was pretreated with 
physostigmine. In both oases, the depolarization rendered 
~he e.p. but not the musole elsewhere eleotrioally inexoitable. 
These experiments were extended by Zaimis and Paton (Za1mis, 
1953 and 1959; Paton and Zaimis, 1949 and 1952). In 1952-1953 
Zaimis was responsible for interesting oonoeptualization that 
depolarizing agents can be effeotive, provided they are long 
aoting, as blooking agents. Aooording to this hypothesis, 
all pharmaoologio actions of depolarizers - musole twitoh 
~pon i.a. administration as well as initial potentiation and 
subsequent blockade of neuromyal transmission - are interre-
~ated and are the r$sult of their capacity to depolarize the 
e.p. At that time then, two 01&$s8s of blooking substanoes 
~ere distinguished, the oompetitively aoting ouraremimetios 
on one hand, and the depolarizing blooking agents, exemplified 
by suooinyloholine (SCh) and by 010 on the other. 
Several additional aotions of depolarizera indeed are 
oonsistent with the oonceptualization of the British in-
vestigators. For instanoe, anti-OhE agents whioh antagonize 
d-tbo, are without effect upon SOh and CIO; some of them 
aotually enhanoe or prolong their blookade (Karozmar. 1957; 
Zaimis, 1959). As oan be expeoted, oompetitive blookers oan 
antagonize the depolarizers; pretreatment with a small, sub-
liminal dose of d-!bo prevents the action of SOh and CIO 
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(of. for instance Karczmar and Fudema, 1957, and Xarczmar, 
1961). In fact. antagonism of SOh and 010 by any other than 
auraremimetio agents was, till reoently (of. below), never 
demonstrated. Finally, depolarizing agents produce charaoter-
istio spastic para1ysis in the pigeon (Zaimis, 1952, 1953; 
Hoppe, 1955), as do sometimes OhE inhibitors (0.0.). 
It appeared subsequently that the status of the so-
oalled depolarization blookade oannot be quite so clear-
out. In a aeries of papers, Theslef! (1955a and b) showed 
that in the frog at least, 010 and SOh blooked the neuromyal 
transmission only after depolarization was over. Furthermore, 
the effeots of methoxyambenonium (WIN 8078) in the oat and 
in the dog (Karozmar and Boward, 1955; Karozmar, 1957 and 1961. 
Lands, Karozmar, Howard and Arnold, 1955) upon 010 , SOh and 
d-Tbo blockade oannot be reoonoiled with the original hypo-
thesis of Za1mis (of. Karozmar, 1956, 1957 and 1961). Karoz-
mar observed that methoxyambenonium antagonized the blookade 
by both curaremimetios and depolarizers; as can be easily per-
oe1 ved from the toregoing, this is a unique property for 
an agent active at the neuromyal junction. 
Furthermore, the antagonism of SOh and 010 by methoxy-
ambenonium takes a rather unusual form (Karozmar, 1956 and 1957 • 
The usual effeot of SOh and 010 upon meol~ioal response of 
the musole to indireot stimulation consists of a brief twitoh 
increase followed by blockade. This blockade 1s converted 
by methoxyambenonium into a continous increase of the twitch 
response, which is not followed by a blookade COlO and SOh 
"reversal"). Karozmar pointed out that if all the actions 
of SOh and 010 depended on the1r depolarizing effeot, the 
increase and prolongation of the twitch inorease due 010 and 
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SOh by methoxyambenonium, should be followed by increased and 
prolonged blockade. The action of methoxyambenonium, interest-
ing because it bears upon original postulates of Zaimis with 
regard to SOh and CIO ' has not been as yet explained; indeed, 
it is difficult to conoeive how a compound which is a weak 
anti-OhE (effective at doses probably incapable to inhibit, in 
vivo, AChE; Karozmar, 1961) oan antagonize d-~bc; the coupling 
of this action of methoxyambenonium with its antagonistic 
actions upon SOh and CI0' is even more perplexing. 
In view of these findings, Zaimis (1959) pointed out that 
SOh and CIO act as pure depolarizers only in the cat fast (white) 
muscles, such as tibialis or sartorius or in a "mixed" muscle 
such as the gastrocnemius. In the case of the slow muscle of 
the cat or in that of most musoles of certain species other than 
the cat, SOh and CIa act as curaremimetic blocking agents, i.e., 
as competitors of ACh. Also, both Za1mis (o.c.) and Foldes 
(1959) point out that, upon repeated administration, the action 
of SCh and CIO can shift, even in the case of fast muscles, 
from depolarizing to competitive. Finally, Blaber (1960) argued 
that anti-CIO effects of methoxyaL;0c;nonium. was obtained in the 
cat, at higher dose levels than ita anti-d-Tbc actions, and this 
suggested that methoxyambenonium may antagonize CIO by preventinE 
it from depolarizing. This, actually, may explain the anta-
gonism between CIa and SCh on one hand and methoxyambenonium, 
but not the "reversal". 
Altogether, it is fair to state that, at present, the 
mechanism of action of depolarizers, as well as that of methoxy-
ambenonium, 1s controversial. 
e. Flexibility of the cholinergic receptor and 
conditioning of the neuromyal junction. 
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It ap.Jeara from the foregoing that several mechanisms 
may exist at the neuromyal junction with regard to antagonizing 
blocking ~cti()n of d-fbc. Anti-OhE agents, fEA. Nal, methoxy-
ambenoni~, and hydromethylammonium compounds may antagonize 
I 
d-Tbc in different ways. Moreover, these and still other 
compounds may &odify the neuromyal transmission by means of 
sev.ral different meohanisms. It should be added that Perry 
(1953) speoulated on synaptio faoilitation, not based on ChE-
inhibition, without specifying the mechanism involved. 
While all this points to the great flexibility of the 
neuromyal junotion, another line of evidenoe indicates still 
another type of control possible at that site. It was shown 
sowe time ago (Koppanyi and Karozmar, 1953; Karczmar, 1955) 
that whole organisms and oertain synapses (Wills, unpublished 
data) may recover function relatively fast after large doses 
of ChE i~~ibitors, before significant regeneration or reacti-
vation ot ChE activity may take place (cf. also Barnes and 
Duff, 1953; McNamara et al., 1954; Robinson et al., 1954). 
Also at the neuromyal junction spontaneous recovery of function 
ocours relat1vely rapidly atter lur~e doses of certain anti-
ChE agents (Wills, unpublished data). While even in the case 
of the SO-Called irreversible ChE inhibitors such as phosphonate 
anti-ChE agents and war gases the reversal of inhibition may 
occur in oertain nerve structUres faster than originally thought 
(Koenig and Koelle, 1960), yet the above data indicate that the 
whole organism or a 3peoific synapse may adapt to low levels of 
ChE's and ooncomitant high levels of ACh. 
Suoh an adaptation to ACh was observed direotly in the 
case of autonomic ganglia (Krlvoy a~d Wills, 1956). At the 
e.p., it was observed (Jatt, l~59) that ACh depolarization 
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decreases in continuous presence of AOh. Further evaluation 
of this problem at the neuromyal junction, and particularly 
data on the adaptation of mechanioal response of indirectly 
stimulated skeletal muscle to AOh are still laaking. 
III. Purpose of the present researoh. 
Analysis of the available pharmaoologio data pertinent 
to the skeletal neuromyal transmission suggest, first of 
all, that the mechanism of aotion of the so-called depolarizer 
blocking agents is not fully understood. Specifically, re-
evaluation of the data of Thesleff (1955a and b) on the re-
lation of depolarization to blockade of meohanical response 
of the muscle is indicated. Jurthermore, the mechanism by 
means of which methoxyambenonium antagonizes d-Tbc and re-
verses 010 and SOh block, is not understood at present. Also, 
further study of newer, not fully understood, anti-d-Tbo 
agents such as TEA and NaF is desirable, partioularly since 
TEA and Nal were not investigated as antagonists of 010 
blockade. The proposed research deals with the effects of 
TEA, NaP and methoxyambenonium upon meohanioal responses of 
the frog muscle to nerve stimUlationA~th the effects of TEA 
and methoxyambenonium the e.p.p_ and muscle membrane; moreover, 
the interaction of TEA and methoxyambenonium with 010 was 
studied in terms of the mechanical and e.p. parameters of 
transmission, and oompared with the interaction of these 
oompounds with d-Tbo. All this should throw additional light 
on the mechanisms of anti-d-fbo, anti-SOh and anti-010 aotion 
of TEA, methoxyambenonium and Nal, and thus on new sites of 
aotion withim the neuromyal transmission pathway. 
Sinoe the results led to a concept of multipliCity of 
sites and mechanisms of the neuromyal transmission, i.e., to 
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the concept of the flexibility and multiple control system 
as being characteristio for this transmission, it was thought 
also important to study among the faotors of this flexibility, 
also the adaptation and reoovery prooesses of the e.p. 
~he exploration of these and still other possibilities 
may throw a light on the important general prinoiple of the 
"modulating" of the Cholinergio neuromyal transmission. 
o. Methodg. 
1. Colleotion of materials and data. 
Dana pipi,ns, the form uBed in this investigation, were 
obtained from a looal supplier. Winter frogs were generally 
employed. Stook animals were kept in an appropriate aquarium, 
and the experiments were run at a temperature optimal for the 
frog nerve-muscle funotion, i.e. at 18-20°0; cooled organ 
bath was used for this purpose. The data oonsisted of photo-
graphic records (obtained by means of the Polaroid and of Du-
mont Oscilloscope Cameras) and of polygraph traoings of musole 
twitch. Sufficient number of experiments were carried out to 
provide statistically dependable numerical values of the per-
tinent parameters. 
2. ~eahnique8. 
Experiments were generally performed on nerve-sartorius 
muscle preparation of the winter frog. The preparation was 
bathed in Ringer solution, in musole ohambers of various types, 
the type depending on the experiment. Ringer solution oonsis-
ted of 115.6 mM BaCL, 2 mM KCL, 1.8 roM CaC12' and 0.2 mM 
NaHCO" the pH was 6.8. In experiments of long duration 
oxygen was bubbled into the solution. 
a. Reoording meohanical response of musole. 
Isometric mechanical responses to indirect and direct 
stimulation were recorded by means of a force transducer 
coupled with Offner Type R Dynograph or with Grass Model 5 
polygraph. ~he muscle was fixed at its pelvic end in the verti-
oal muscle bath and connected by means of its tendon with the 
force transducer. When an indirect stimulus was employed, 
the nerve was separated from the muscle and suspended from 
platinum eleotrodes. ~he stimulator employed was from American 
Electronic Laboratories (Model 1041). Generally, the single 
st imulas had the streIl8th (in the case of supI'8.max1mal shocks) 
of 1 to 5v, duration of 2 to 50 ms. Direct stimuli to the 
muscle were also employed at the stimulus strength ofl to 8 v. 
to ten 
Trains of fiveAstimuli, one stimulus every 1 second, were em-
ployed. the interval between each train being 5 to 10 minutes. 
There was a diminution of up to 20 per cent of twitch height in 
the controls within 2 to 3 hours. Aocordingly, the twitoh ob-
tained after an experimental prooedure was oompared to that re-
corded Simultaneously in the oontrol preparation. This was 
particularly done to asoertain whether or not TEA or methoxyam-
benonium, used alone or in combination with ClOt increased the 
musole twitoh above the control levels. 
b. Measurements at the e.p. and at the muscle 
membrane. 
Essentially, the following parameters were studied per 8e 
and with regard to the aotion of drugs ~nd drug oombination; 1) 
the resting potential of the muscle fiber and of the e. p., 2) 
the action potential of the muscle, 3) e.p. depolarization, 4) 
the e.p.p. Intracellular and extracellular measurements were 
employed. 
In the former case capillary microelectrodea (Ling and 
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Gerard type) were drawn by means of a micropipette puller, 
(Industrial Science Assooiates Inc.) The micro-electrodes had 
a tip diameter of less than 0.5 p_ They were filled with KCl 
by boiling in 3 M KCl solution, and showed a resistance of less 
than 20 megohms. In the measurement of the resting potential 
and of the e. p. p., the muscle wa.s suspended in a. vertical J.luscle 
bath, treated with a solution ot d-Tbc or 010 sufficient to 
block transmission (generally 5 x 10-6 and 3 x lO-6M, respective~ 
ly), the solution discarded, and the e.p.p., induced by supra-
maximal volleys to the nerve, was tested. The microelectrode 
was oonneoted to a cathode-follower input stage, and its outF4t 
connected to two amplifiers and to cathode-ray tubes (!echtronix 
Model 502). Resting potentials were observed by the cathode-
ray tube com4eoted to a d.o. amplifier. The same setup was 
employed to reoord the miniature endplate potentials (m.e.p.p.'s • 
Extraoellular eleotrodes were mainly used to measure the 
persistent depolarization of the e.p_, shown by a difference in 
surface potential between the nerve-free pelvic end of the sar-
torius and the e.p. region. The muscle-nerve preparation was 
mounted, in a vertical perspex chamber, in the Ringer bath. 
One Ag-AgCl eleotrode was plaoed on the pelvic end and the other 
made contact with the fluid below the tibial end. The distri-
bution of the surface pot ent 1a.l was mea.sured by means of an 
arrangement allowing the movement of the muscle with respeot 
to the surfaoe of the fluid which acted as a movable electrode 
(Del Castillo et al., 1956a). All preparation with initial 
potential of over 0.5 mv were discarded. It should be pointed 
out at this time that the muscle has to be disseoted and pre-
pared with utmost care to prevent injury. 
In these experiments the location of the e.p. had to be 
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TEA and methoxyambenonium, alone or in combination with C10' 
on endplate sensitivity to ACh, each treatment was followed 
by several washes and by a test of ACh depolarization to as-
certain that the neuromyal junction returned to control con-
ditions prior to the next procedure. Somewhat different se-
quences of exposures are described in the legends to various 
figures and in the text. 
D. Results. 
I. Effects of pharmacologic Agents on meohanical response 
of th! muscle. 
1. Effects of methoxyambenon:i:um and of ChE inh.ibitors. 
In the case of maximal or supramaximal stimulation of the 
nerve, methoxyambenon1um did not increase the tvi toh amplitude 
over a wide range of conoentrations (0.5 x 10-7 to 10-5 ; 15 
experiments); stronger conoentration (10-~ and higher; 14 
experiments) caused slowly deVeloping blockade which became 
complete within 30 to 50 minutes when the weaker ooncentration 
was used and faster with stronger concentrations (fig. 1). 
Also in the cat methoxyambenonium did not increase the twitch 
of indirectly stimulated muscle (Karczmar, 1957). It may have 
been expected that, as in the cat, so also in the frog, in-
effectiveness of methoxyambenonium could be contrasted with 
the well-known effectiveness of ChE inhibitors in increasing 
the twitch height. ~his proved not to be the case, and the 
potent anti-ChE agents, such as eserine, ambenon1um and neostig-
mine, proved incapable over a wide range concentration to 
potentiate the twitch. With higher concentrations blockade 
could be observed; weak blockade occurred, for inatance, in the 
case of 5 x 10-6M concentration of ambenonium (4 experiments) 
and more complete blockade in that of 5 x 10-5M concentration 
27. 
(3 experiments). 
While generally not desoribed in the literature, this 
lack of effeot of anti-ehE agents upon the twitoh of indirectly 
stimulated frog musole is known (Koketsu, personal oommunioatio~). 
It should be remembered that, in the mammal, it is difficult 
to potentiate by means of anti-ObE agents the response to 
preganglionic stimulation (McIsaaohs and Koelle, 1959), unless 
the preganglionic nerve trunk is longitudinally split and a 
thin strand used for the stimulation, or unless submaximal 
stimulation is used. 
It was aooordingly attempted to test the effeot of drugs 
upon the twitoh amplitude in the frog:after technioally diffi-
oult splitting of the motor nerve, or by using submaximal 
stimuli. In these oonditions, methoxyambenonium (1-5 x 10-~) 
inoreased the twitoh height in 12 out of 22 experiments from 
20 to 40 peroent. 
~he augmentation lasted tor relatively short time periods 
(3 to 10 minutes); ambenonium and neostigmine proved more 
effeotive, inoreasing the twitoh from 30 to 50 peroent; also, 
the inorease lasted longer (5 to 15 minutes; 5 experiments per 
oompound). 
1inally, TEA (0.; to 1 x 10-3.) did not augment muscle 
twitoh whether supra- or sub-maximally stimulated (15 experi-
ments); in higher conoentrations (5 experiments) TEA produoed 
initial inorease of musole twitch amplitude; this was rapidly 
followed by blookade. It should be pointed out that, in the 
past, tEA was found to inorease the twitch of indireotly sti-
mulated frog sartorius (Ing and Wright, 1933). This was also 
demonstrated in the kitten but not in the adult cat (Sullivan 
and Kensler, 1950). 
It should be stated that neither TEA (5 x 10-5 to 
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5 x 10-3M) nor metho~ambenonium (10-7 to lO-4M) had any signi-
fioant effeot, within a wide range of conoentrations, upon the 
twitoh of the direotly stimulated muscle (15 experiments per 
oompound). 
2. Interaction between ClOt methoxyambenonium and 
TD. 
010 (3 x 10-6 to 1.5 x lO-4M), produoed, as is well known, 
blookade of indireotly, supra-maximally stimulated frog musole 
(22 experiments). Interaotion between C10 and ~EA or methoxy-
ambenonium was studied using eupramaximal stimulation of either 
the divided or the intaot nerve, or em~loying eubmaximal sti-
mulation. With intaot nerve and supramaximal stimulation, 
methoxyambenonium, used at the point of almost oomplete 010 
blookade, produoed partial restoration of transmission only 
rarely (fig. 2; 3 out of 15 experiments). However, more oon-
sistant partial antagonism between C10 and methoxyambenonium 
(3 x 10-6 to 1.5 x 10-4M) ooourred whenever divided nerve or 
submaximal stimulation was used (12 experiments, fig. 3). TEA 
(3 x 10-4 to 10-3M) was more effeotive against 010 than methoxy-
ambenonium (10 oases); it produoed regularly marked restoration 
of transmission whioh was blocked by 010' whether sub-maximal 
or supra-maximal stimulation was used (10 experiments; figs. 4 
and 5). Particularly in the oases of sub maximal stimulation, 
the musole twitoh depressed by 010 was augmented by fEA to a 
height above that of oontrols obtained prior to 010 (6 experi-
ments; fig. 5). The effect of TEA was espeoially pronounoed 
in the case of the first few responses; the twitoh amplitude 
subsequently deoreased (fig. 4). 
Several other agents were tried as possible 010 antagoniste. 
Hal (5 x 10-3M to 5 x 10-5M), a "sensitizer" of the e.p. (of. 
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Introduction, and Koketsu and Gerard, 1956), had negligible 
effect on C10 blockade when supramaximal stimulation was 
used (5 experiments); it exhibited antagonistio aotion when 
sub maximal stimulation was used (7 experiments). The re-
storation of the twitoh height amounts to about 30 percent. 
Anti-Chi agents, ambenonium (10-7 to 10-5H), neostigmine 
(10-6 to 5 x 10-5H), and eserine (0.5 to 1.0 x 10-5M) had 
no effect upon 010 blookade of maximally stimulated nerve-
musole preparation (15 experiments per oompound); in fact, 
as sometimes in the mammal (Karczmar, 1957 and 1961), these 
oompounds increased the blookade under these oiroumstanoes 
(fig, 6). When submaximal stimulation was used, partial 
(about 20 percent). temporary (3 to 5' minutes) restoration 
of transmission was sometimes observed. This was most 
notioeable in the case of neostigmine. An interesting result 
was notioed when neostigmine in relatively weak (10-7 to 
10-6.) ooncentrations was employed simultaneously with C10 ' 
(8 experiments; fig. 7). Under these oiroumstanoes, neostig-
mine delayed the onset of 010 blockade. This effeat was 
not observed when eserine (9 experiments) was applied si-
mul.neously with ClOt It is of interest that in a few ex-
periments, a oombination of eserine (5 x lO-~) and of 
methoxyambenonium (5 x 10-6M) oaused partial restoration of 
transmission blooked by C10 ' even when supramaximal indireot 
stimulation was employed (in 7 out of 8 experiments; fig. B). 
Other than eserine anti-OhE agents were not employed in oom-
bination with methD~yambenonium. 
It appears from this section that Til, methoxyambenonium 
and Nal, are, in this sequenoe, most effeotive antagonists 
of 010 blo ckade, ant i-OhE agents being ineffeoti ve in this 
respect. 
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3. Interaction between d-fbc, TEA and methoxyam-
benonium. 
Generally, 3 to 5 x 10-6X concentration of d-Tbc was 
used to cause neuromyal b~~ckade of the indirectly stimulated 
frog nerve-muscle preJ;aration; used at this strength. d-~bc 
generally caused a 70-90 percent reduction of the twitch. 
Methoxyambenonium (1.0-2.0 x 10-6M; 12 cases) caused, within 
a few minutes, restoration of transmission lasting from 5 to 
10 minutes (fig. 9); however, blockade returned subsequently. 
Faster deblocking as well as more rapid return or intensifi-
cation of original d-Tbc blockade was:noticed with stronger 
concentrations of methoxyambenonium. 
fEl had similar, biphasic effect upon curarized muscle. 
Weaker concentrations (3 to 5 x 10-4M; 15 experiments) produced 
restoration of transmission without subsequent blockade (fig. 
10).Asin the case of the effects of TEl upon C10-blocked 
transmission, the action of TEA was particularly pronounced 
C().$e of the in theAfirst few responses. With higher concentration of TEl, 
the mechanical responses were initially augmented and gradual-
ly depressed. fhis confirms the earlier data of Koketsu (1958). 
4. Effects of ACh in various experimental conditions, 
on the response of the indirectly stimulated 
muscle. 
~he most conspicuous action of effective concentration 
of ACh was its blocking effect upon transmission. This was 
noticed with a relatively wide range of ACh concentrations. 
Yet, it became apparent that ~itch increase may be obtained 
with this agent, since frequently, after the depressant action 
of AOh was recorded and the preparation washed with Ringer, 
the twitch amplitude was increased by 20 to 40 percent, 
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presumably beoause traoes of ACh remained on the reoeptor 
(12 .xperimentsj fig. 11 and 12). It was not easy to find 
the concentration of ACh capable of increasing the twitch 
amplitude without recurring to washing; however, several 
experiments (18 out of 35) could be carried out in whioh 
ACh (5 to 7 x 10-6M) caused inorease of twitoh amplitude 
(f~. 11). In this respeot, ACh resembled C10 exoept that 
facilitatory effect of CIO oould be more easily demonstrated 
than that of ACh (cf. belOW p.3S). 
Negligible reoovery was generally notioed with the 
ooncentrations of ACh oapable of pro~ucing marked neuromyal 
depression (10-5 to 10-4M). fhis was true even when experi-
ments were oarried out for 3 or 5 hours. It should be, how- . 
ever, pointed out that oontrols also exhibit reduction of 
the musole twitoh over oomparable time periods (of. Methods), 
and that therefore some reoovery may have set in but was 
masked by deterioration of the preparation. fhis effeot 
of strong oonoentrations of ACh resembled that of CIO, whioh 
was also found essentially irreversible (of. below p~). 
However, in the oase of weaker oonoentration of ACh 
(5 x 10-6 to 10-5M), which produoed relatively small, less 
than 50 peroent depression of transmission, reoovery oould 
be observed repeatedly. It frequently ooourred within 5 
minutes of the onset of blockade (figs. 12 and 13). Similar 
results were reoently reported by Smith (1960). It is of 
interest that in the presenoe of neostigmine spontaneous 
reoovery would also ooour (figs. 13 and 14; 9 experiments 
out of 15), when weak concentrations of ACh were employed. 
It should be pointed out that, in the !a !!!2 experiments 
in whioh AOh was administered i.a. or i.v. to oats or dogs to 
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produce neuromyal actions, the ACh could be disposed of by 
combined action of ChEfs, tissue diffusion, and removal by 
the blood stream, but in the !a vitro experiments ACh remains 
in touch with the muscle throughout the whole experiment. 
Thus, the recovery was spontaneous and oocurred in the con-
tinuous presence of ACh. It could be stated that the re-
covery constituted a case of adaptation to depressant levels 
of ACh. 
Another instance of adaptation to ACh was demonstrated 
in experiments conducted somewhat differently from the pre-
vious ones. In these experiments, the preparation was "con-
ditioned" to increasingly higher a~d higher concentrations of 
ACh; it could be shown that, after the "conditioning", even 
a strong concentration of ACh (5 x 10-5M), capable of marked 
blockade of an "unconditioned" preparation, was ineffective 
(11 experiments). In other experiments of this type, con-
centrations of ACh, effective in control experiments, were 
found ineffective in "conditioned" muscles (12 experiments; 
figs. 15 and 16). This, then, is a case of ACh tachyphylaxis, 
which was so far described only by Smith (1960). It should 
be pointed out, however, that conditioning could occur only 
with concentrations of ACh capable of slight, 20 to 25 percent, 
blockade (fig. 16). In other words, ACh tachyphylaxis was 
never pronounoed. 
As already stated (cf. section 2 above). anti-ChE 
agents frequently synergized with CIO in the production of 
transmission blockade. Similarly, ACh generally synergized 
with neostigmine and eserine in the production of the blockade. 
In the presence of neostigmine (10-6 to 10-7M) or of eserine 
(10-5 to 10-4M), it sufficed to employ 10-7 to 5 x 10-~ 
concentration of ACh to produoe 30 to 50 percent blockade of 
transmission. when used alone, ACh had to be used in conoen-
trations of 5 x lO-5X or higher to produoed similar degree 
of blookade (of. supra). As desoribed before, weaker concen-
trations of ACh and of neostigmine did not produce blookade 
(fig. 13). 
Another agent which produced blockade SYl:ergistically 
with ACh was methoxyambenonium. As already described, used 
alone, methoxyambenonium never produced any blockade at 
concentration lower than 1.5 x lO-5X (of. Section 1 above). 
while ACh was never markedly depressant at less than 10-~. 
Used jOintly, these agents were markedly blooking at concen-
trations of 10-ax of AOh and 10-7M o£ methoxyambenonium (6 
experiments). The reoovery from suoh blockade was slight 
within the usual experimental duration (2 hrs.). 
5. Effeots of C10 upon the response of the indirect-
ly stimulated muscle. 
010 effect upon neuromyal junotion differed in several 
respeots from that of ACh. In the first plaoe, it was re-
latively easy to obtain inorease of the twitoh response with 
ooncentrations ranging from 10-6 to 10-5M• In the case of 
weak ooncentrations of C10' twitch increase lasted for the 
whole experimental period (up to two hours; 12 oases; fig. 17). 
This effect of 010 can be contrasted with that of ACh, in 
whioh case twitch inorease oould not be easily demonstrated, 
and when obtained, it was only ~emporary. In the oase of 
stronger concentrations of CIO ' the initial twitch increase 
subsided and progressive blookade took plaoe, the rate of the 
ocourrence of the blockade depending upon conoentration. The 
blockade was complete in 30 minutes in the case of 5 x 10-5K 
solution of 010. !he following finding was also of interest. 
In the control preparation, as well as after the twitch 
magnitude was increased by a weak conoentration of C10 ' a 
typioal "treppe" effect was observed in most of the cases (figs. 
17 and 18). 
As already stated, spontaneous reoovery was not notioed 
in the oase of either faoilitating or blocking conoentrations 
of 010. Iven in the case of concentrations of 5 x 10-6 to 
6 x 10-5• of 010' produoing some facilitation first and re-
latively slight blockade within 30 or 40 minutes, no reoovery 
but rather progressive blockade, terminating in complete block 
within 1 to 2 hrs., was noticed. This constitutes then another 
difference between C10 and ACh. 
'inally, adaptation phenomena were never notioed with 010. 
In several experiments, 010 solutions (10-6 to 5 x 10-~) 
causing some twitoh increase at first and some blockade later, 
were replaced, when blockade ensued, by somewhat stronger 
solutions (6 x 10-5 to 10-5.); in all oases increased blookade 
was observed. When the preparation was washed in Ringer 
between the two applications of C10 ' the block increased when 
the preparation was placed in the second 010 solution (fig. 19). 
Bven when stronger solution was substituted for the weaker 
solution at the time when the latter produced twitoh inorease 
only, blockade oocurred. This, non-adaptive behavior of 010' 
again differed from the taohyphylaxis effect notioed in the 
case of ACh. 
II. )ffects of pharmacologic agents at the endplate. 
1. Effects of methoxyambenonium, ~EA and 010 on 
muscle membrane and at the endplate. 
It was determined, first of all. that neither methoxyam-
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benonium (1.5 x 10-7 to 1.5 x 10-4X), nor CIO (3 x 10-6 to 
1.5 x 10-4M) nor finally !EA (10-3 to lO-5M) had any effect 
on both the resting and action potenttal of single fibers. 
~EA and methoxyambenonium resembled each other in that they 
did not have any direct effect upon the resting potential of 
the e.p. in oonoentrations ot 1.5 x 10-7 to 1.5 x lO-6:M. ~hus, 
they are not depolarlzing agents; also, they presumably have 
no direot myogenic aation, as already suggested by the laok 
of their aotion upon the directly stimulated frog muscle (cf. 
supra, Seotion 1-1). 
Methoxyambenonium showed one lnt~resting activity at the 
e.p. in whioh it differed from ~EA. At a relatively low 
concentration of 5 x lO-~, methoxyambenonium increased the 
amplitude (by 0.5 : 0.1 mv), but not the frequency of m.e.p. 
p.'s (fig. 20; 250 ~ 18/30 minutes; 7 experiments) while TEA 
did not seem to affect the m.e.p.p.'s. It appeared that, at 
optimal conoentrations (10-6 to 5 x 10-5M), eserine did not 
produce as much effect upon m.e.p.p.'s as methoxyambenonium 
(fig. 20). Control m.e.p.p.'s showed an average of 0.3 to 
+ 0.1 my, while after eserine they averaged 0.4 - 0.1 mv. 
010 had, as it is well known, a depolarizing action 
at the e.p.t whioh was obtained with ooncentrations of 10-7 
to 1.5 x 10-4M. This action of CIO was almost entirely confin d 
to the e.p. 
2. Effects of TEA and methoxyambenonium on the e.p.p 
E.p.p. was obtained by blocking the transmission either 
by 010 (generally 5 x 10-6M) or by d-Tbc (generally 3 to 5 10-
M). 
With regard to curarized preparatio~ the a.p.p. action 
of methoxyambenon1um was, interestingly enough, very different 
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from that of TEA. In briet. methoxyambenonium markedly aug-
mented the e.p.p. (fig. 21). Measured extracellularly, the 
e.p.p. varied between 2 and 4 my; measured intracellularly, 
between 10 and 30 mY. The augmentation amounted to 1.2 ~ 0.3 
mv and 10 .!. 0.4 mv, measured extra- and intra-cellularly, 
respectively. Yet, even when concentrations of methoxyambenoni 
reversed the aotion ot d-tbo (1.5 x lO-4M) and the e.p.p. was 
increased past the oritioal depolarization potential whioh pro-
duoed a spike, repetitive tiring was never notioed. !he effect 
was prolonged and consistent. All •• p.p.'s of any particular 
train of stimuli were affeoted similarly. still higher con-
centrations tended to lower the e.p.p.t s • Pinally, methoxy-
ambenonium did not change the pattern and shape ot the e.p.p.; 
particularly, the falling phase of the e.p.p. was not prolonged 
(tig. 21). Per instanoe. in the case of 1.5 x lO-6r.t methoxy-
ambenonium solutions the time value of the decline ot the e.p.p. 
to half its peak value was 1.8 ~ 0.4 ms, and thus was quite 
similar to that of the oontrol e.p.p. (1.7 ~ 0.4 ma), although 
the latter was half the height of the tormer. fhus, methoxy-
ambenonium oaused augmentation but no prolongation ot the 
e.p.p. ot curarized preparation. 
While TEA also inoreased the e.p.p. ot the curarized 
preparation, this augmentation differed from that produoed by 
methoxyambenonium. !El, 2 x 10-4M to about 5 x 10-4M (thres-
hold conoentrations and higher), produoed augmentation pro-
portional to TEl concentration, combined with prolongation 
ot the falling phase of the e.p.p. (duration ot decline to half 
the peak value 2.1 1 0.5 ms). In taot, the e.p.p. pattern 
was ohanged generally: the latenoy and the rising phase were a,Iso 
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prolonged, although the falling phase and the duration of the 
e.p.p. were mO$t affected. It was also noticed that the 
effect of !J4 was most oonspiouous in the case of the first 
e.p.p.' s of .eacn train of stimuli; repeated stimulation of 
the nerve bro~ht about e.p.p.'s of oontrol size and shape. 
In the case of these earlier e.p.p.'s, TEA (5 x 10-~) pro-
duced augm~tation amounting to 1.5 ± 0.3 mv and 14 ~ 0.4 mv, 
measured extra- and intra-cellularly, respectively. 
Higher (10-3 to 3 x 10-3M) concentration of fEA caused 
manifold e.p.p. ohanges. Repetitive firing and considerable 
augmentation and prolongation of the first e.p.p.'s of eaoh 
train of stimuli were notioed; depression of subsequent a.p.p.' 
a of eaoh train of stimuli tollowed. 5 x lO-3M concentrations 
and higher led to immediate decrease of the e.p.p.'s in 
absence of repetitive tiring. Some ot theae observations 
were already reported by Koketsu (1958). 
It was of particular interest to record the changes 
produced by methoxyambenonium and Til upon the e.p.p.'s ob-
tained when the transmission was blocked by 010. This e.p.p. 
was generally smaller than the e.p.p_ obtained in curarized 
preparations (fig. 22 and 23). The rather surprising finding 
waa that the efteot ot methoxyambenonium and of TEA was 
essentially similar or even identical with that produced by 
these agents in the oase ot the e.p_p.'s of curarized pre-
parations. Again, TEA increased and augmented the e.p.p., 
when used in lower oonoentrations (3 x 10-4 to 5 x 10-3M); 
used in these conoentrations, TEA inoreased the e.p.p. by 
1.4 ~ 0.4 mv (extraoellular recording). In higher conoen-
trations (lO-4M) TEA. actually produoed repetitive firing 
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(fig. 22). As before, the restoration of the e.p.p. was 
Iarticularly noticeable after the first nerve stimulation; 
thereafter, subsequent stimuli produced smaller e.p.p.'s. 
Higher concentration of TEA (5 x 10-4 to 10-3M) decreased the 
e.p.p. due to CIO' just as it decreased the e.p.p. of curarized 
preparations. 
As in the case of e.p.p.'s of curarized preparations, 
the effects of methoxyambenonium upon e.p.p.'s obtained in 
the presence of CIO resembled those of TEA in one respect and 
differed in several others. Methoxyambenonium (5 x 10-5 to 
-6 5 x 10 M) augmented but did not prolong the e.p.p. (fig. 23). 
The effect was consistant, i.e., e. p. p:. 's obtained by first 
stimuli of each train were not augmented more than those due 
to subsequent stimuli. However, neither repetitive firing nor 
prolongation of the e.p.p.'s was produced by methoxyambenonium 
within this range of concentrations. 
It is well known that anti-ChE agents produce an increase 
of e.p.p.'s of curarized preparations, and, in the case of 
higher concentrations, spiking and repetitive firing (cf. for 
instance, Nastuk and Alexander, 1954); one of the most con-
spicuous e.p.p. effects of anti-ChE agents was the prolongation 
of the falling phase of the e.p.p. These data could be re-
produced at present. In the case of eserine, the duration 
of the decline to half the peak value was 2.5 ! 0.5 ms, as 
against 1.7 ±. 0.4 ms duration in the control experiments (fig. 
23). On the other hand, anti-ChE agents (for instance eserine, 
10-6 to 10-5M) did not increase the e.p.p. when the trans-
mission was blocked by C10 ; the only effect notioed with these 
and higher ooncentrations of eserine was a decrease of the 
e.p.p. amplitude (fig. 23; 8 experiments). 
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3. Endplate action of 010 (3 x 10-6 to 1.5 x 10-~) 
was measured in these experiments simultaneously 
with the reoording of the musole twitoh. 
these measurements entirely oonfirmed the conolusions of 
~hesleff (1955a and b) that 010 depolarization in the frog is 
temporary, and that its time course is different from tllat of 
its transmission blookade. 
When measured with the external electrodes, depending upon 
010 ooncentrations,maximum depolarization varied between 2 and 
7 my, reaohed its peak within 1 to 15 minutes, deoreased sub-
sequently and oompletely subsided within 15 to 50 minutes 
(fig. 24). At the same time the blookade of meohanioal muscle 
response to indirect stimulation was first noticed well after 
depolarization; as the muscle repolarizedthe maximal blookade 
ot transmission ooourred well afte~ oomplete return of e. p. 
membrane to nor.mal polarization (fig. 24). 
4. Analysis ot 010 blookade of neuromyal transmissio~, 
and of its antagonism by ~EA and by methoxyam-
benonium. 
Since the above data indioate that 010 depolarization 
oannot account for transmission blockade, the experiments of 
Theslef! (0.0.) indicating that this blookade is due to ACh 
"desensitization- of the e.p. were repeated and expanded. 010 
in all ooncentrations oapable of initial depolarization and 
subsequent blookade (10-6 to lO-4M) decreased AOh depolarization 
at the e.p. ~e pattern of AOh depolariZation was, essentially, 
not affected; in the presenoe of 010' the time course of AOh 
depolarization was parallel to that due to AOh alone (15 ex-
periments; figs. 25 and 26). Sinoe this suggests competition 
between 010 and AOh, it may be predioted that ~EA and methoxy-
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ambenonium, antagonists of CIO transmission blockade, would 
sensitize the e.p. to ACh. Yet, this did not prove to be the 
case with TEA. Actually, the effect of TEA upon ACh depolari-
zation was very similar to that of CIO itself (12 experiments; 
fig. 25); this confirms the data of Koketsu (1958). 
On the other hand, methoxyambenonium (5 x 10-6 to 10-5M) 
markedly increased ACh depolarization by 2.1 ~ 0.5 mv (exter-
nal electrode measurement) in the case of stronger concen-
trations. An interesting feature of this sensitization was, 
that again, a family of parallel curves was obtained; ACh de-
polarization in presence of methoxyamb~nonium was increased 
over, and parallel to, that caused by ACh alone (11 experiments; 
fig. 27). In other words, methoxyambenonium increased but did 
not prolong ACh depolarization. In this, the methoxyambenonium 
effect differed markedly from the well-known action of anti-
ehE agents, which as well as augmenting it prolongs ACh de-
polarization (13 experiments; fig. 28). Finally, at relative-
ly high conoentrations (10-4M), methoxyambenonium depressed 
ACh depolarization (fig. 27), i.e., it desensitized the e.p. 
to ACh. 
A reference should be made at this time to the blookade 
of neuromyal transmission recorded when a combination Jf very 
weak concentrations of methoxyambenonium (lO-7M) and of ACh 
(lO-8.M; cf. p. 36) were tested. It could be shown at present 
that, employed in these concentrations, neither agent nor 
their combination produoed measurable depolarization. On the 
other hand, when the block was produced by combining ACh with 
anti-ChE agents such as eserine and neostigmine (of. p. 36, 
p.: 32), the effective oonoentrations (10-5 to lO-~) of ACh 
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could produce some depolarization, which was markedly intensi-
fied by the anti-ChE agents at concentrations employed (14 
experiments; fig. 28). 
It appears that whlle sensitization of the e.p. to ACh 
may be underlying the antagonism between methoxyambenonium 
and ClOt TEA must antagonize CIO by its e.p.p. action, since it 
actually desensitizes the depolarization of ACh. This could 
be substantiated by additional lines of evidence. 
First, it could be shown that CIO synergizes with d-Tbc. 
When CIO (10-5 to 10-6X) was added to a curarized preparation, 
the e.p. was first augmented; then, sirice the resting potential 
of the e.p. was raised by the depolarizing action of CIO ' the 
e.p.p. was decreased. Finally, when the CIO depolarization 
subsided, the base-line returned to normal and the e.p.p. was 
markedly reduced. With higher concentrations of CIO and d-Tbc 
(at concentrations of both agents of 10-5M), e.p.p.'s were 
completely blocked. TEA could increase the height and the 
duration of e.p.p.'s obtained by combined use of CIO and d-Tbc, 
producing repetitive firing with 10-4X concentrations. As in 
the case of e.p.p.t s produced in the presence of C or d-Tbc 10 
alone, methoxyambenonium again resembled TEA in antagonizing 
e.p.p.'s obtained in the presence of C10-d-Tbc combinations; 
again, it neither prolonged s.p_p.ts nor caused rep6titive 
firing. 
In another experimental series, AOh sensitivity was de-
creased by CIO ' and the effects of TEA and of methoxyambenonium 
upon desensitized e.p. measured. TEA (0.1 - 0.5 x lO-4M) could 
never restore the e.p. sensitivity (fig. 29). Actually, at 
higher concentrations, TEA additionally reduced ACh depolari-
zation after its partial reduction by 010 • This could be 
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expeoted on the basis o~ the blooking actions o~ TEA upon AOh 
depolarization (vide supra). To the oontrary, methoxyambenonim 
in conoentrations o~ 5 x 10-5 to 5 x 10-~ could at least 
partially restore AOh depolarization reduced by 010 (15 experi-
ments; fig. 26). The average inorease was 1 ± 0.' mv (extra-
oellular recording). As in the oase o~ the depolarization pro-
duoed by AOh in the absenoe o~ CIO ' methoxyambenonium aug-
mented, but did not prolong ACh depolarization obtained in the 
presenoe of 010 • Finally, stronger oonoentrations of methoxy-
ambe~onium additionally decreased AOh depolarization, already 
reduced by 010• In other words, methoxyambenonium exhibited 
in this, as in cany other experiments, biphasic aotion. 
5. AOh depolarization and neuromyal blockade. 
The time course of AOh depolarization was compared in 
these experiments to that of AOh blookade of neuromyal trans-
mission. At concentrations of 5 x 10-6 to 5 x 10-5M of AOh, 
depolariza~ion measured with external electrodes reached within 
1 to 2 minutes a peak of from 3 to 8 mv. 
Thereupon, in spite of the oontinued presence of AOh, or 
application o~ a fresn solution, the depolarization deoreased 
and subsided in ~rom 10 to 15 minutes, depending on AOh con-
centration (~ig. 30 to 32). The response of the musole to 
indireot stimulation, on the other hand, followed a dif~erent 
time oourse, sinoe it was first notioed at a oJnsiderable time 
after the peak o~ depolarization was reached, and sinoe it 
reaohed its maximum a considerable time a~ter the depolarizatio 
was over (more than 100 experiments; ~ig. 30). Recovery ~rom 
the blookade of transmission ensued later. In other words, the 
e.p. potential exhibits two funotionally very dif~erent phases 
of AOh action; the first phase immediately a~ter the reversal 
o~ AOh depolarization, when AOh blocked muscle response to 
indirect stimulation; and the second phase when reoovery from 
transmission blockade oOuld be observed. 
During both these phases the e.p. was resistant to de-
polarization aotion. In the oontinous presence of ACh, 
eserine and neostigmine oould not restore depolarization (15 
experiments; fig. 29); methoxyambenonium was also ineffective 
under theae conditions. However, increasing the ACh ooncen-
tration produced $ome slight depolarization, even when the 
conoentrations of ACh in question were oapable, prior to first 
administration of ACh, of producing maximal (8 mv) depolariz-
ation (fig. '2). Even half-an-hour after the cessation of ACh 
depolarization, ACh sensitivity of ;the e.p. did not return to 
normal, i.e., strong conoentrations of ACh could produce, at 
this time, only small depolarizations. Pretreatment with 
eeerine prior to adding either high or low concentrations of 
ACh did not increase the eftect of the latter; in fact, 
eserine seemed to decrease the effeotiveness of ACh in de-
polarizing the desensitized e.p. On the other hand, methoxy-
ambenonium at 10-6 to lO-7M produoed, combined with 10-9M ACh, 
the highest depolarization of which the desensitized e.p. 
seemed to be capable, although even this depolarization (3-5 
my, 12 experiments; fig. 32) was significantly short of the 
maximal depolarization whioh ACh could produoe in a fresh e.p. 
The effectiveness of methoxyambenonium was not increased by 
employing stronger concentrations of this compound with AOh 
in various concentrations (10-5 to 10-~). 
E. Di89u8,1on. 
Two major problems will be considered in this discussion. 
One problem concerns the mechanism of 010 blookade, and that 
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of the interaotion between 010 and various pharmaoological 
agents, particularly as it refleots on the mechanisn. of the 
antagonism of CIO by TEA and methoxyambenonium. The other 
problem 1s related to the effects of ACh at the e.p. and upon 
the neuro~al transmission, and it deals also with the com-
parison of the neuromyal effects of ACh and C10. 
1. Mechanism of the blockad. by CIO of froS 
neuromyal transmission. 
a. Blocking action of CIO at the neuromyal 
junction. 
It seems likely that, as already proposed by Thesleff 
(1955a and b), 010 blockade of the neuromyal transmission in 
the frog is not due to depolarization. He cited several lines 
of evidence indioating just this; perhaps the strongest one 
being the differenoe between the time course of 010 neuromyal 
blockade and that of 010 e.p. depolarization. A.lso, simultane-
ously with produoing the neuromyal blockade, 010 desensitized 
the e.p. to AOh, and the pertinent experiments suggested that 
these two oompounds may compete for the reoeptor site. All 
these results could be confirmed at present. Moreover, in some 
of the experiments described herein, the a.p.p.'s could be 
deoreased or even oompletely flattened by either excessive oon-
oentrations of d-fbc and 010' or by 0lO-d-Tbc combinations~ 
these experiments suggest that d-fbc and 010 synergize with 
each other, and have a similar mechanism of action. Finally, 
the results obtained at present demonstrate the antagonistic 
action of methoxyambenonium and TEA upon 010 blockade, and show 
that this antagonism is similar to that which methoxyambenonium 
and TEA exert with regard to d-Tbc. It is diffioult to explain 
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these antagonisms without assuming that C10 blockade is due 
to desensitization of the e.p. to ACh, although even then the 
full understanding of these phenomena is not easy, as will be 
shown below. 
b. Anti-C10 effects of TEA, methoxyambenonium 
and NaF. 
It should be stressed that these agents not only antagon1~ed 
C10 ' but also d-Tbo blockade. If C10 blocks by ACh desensiti2~ 
ation or, possibly, by competing with ACh, and if this block j~, 
therefore, similar to that produced by d-Tbc, antagonism of bc~h 
C10 and d-Tbc by one and the same compound should be expeoted. 
While this-concept would explain the "double" antagonism of d-
Tbc and ClOt exhibited by TEA, methoxyamhenonium and NaF, it 
offers also difficulties. One would, for instanoe, expect, tlat 
CIO,as a desensitizer of the e.p. or as a competitor of ACh, 
should be antagonized by anti-ChE agents; yet, as in the mammal 
(Zaimis, 1959; Karozmar, 1957 and 1961), so also in the frog 
CIO blockade is, if anything, deepened by ChE inhibitors suoh as 
ambenonium, eserine and neostigmine. Also, anti-ChE agents d4-
press the e.p.p. obtained in the presence of C10 • It should 1:e 
pointed out that the anti-ChE compounds employed are very potEnt 
inhibitors of AChE and thus should easily produce ACh accumu-
lation capable of depolarizing even a desensitized e.p., whicI 
is one of the possible mechanisms underlying the antagonism 0 
neuromyal blockade (Riker, 1953). In view of the ineffective-
ness of anti-ChE agents, it may be suggested that the anta-
gonism depends rather upon displacement of the blocker by the 
antagonist, as proposed by Riker (o.c.), and that the anti-Ch 
agents in question cannot displace CIO because they do not ex 
hibit sufficient affinity to the neuromyal junction. However 
it is not likely that lack of antagonism of CIO ' partioularly by aD 
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benonium, is due to the lack of affinity to or activity of 
this compound at the e.p. Indeed, ambenonium produces direct 
muscle effect (Karozmar, 1957; Land et al., 1955) and actions 
upon neuromyal transmission at the levels of less than a 
microgram, and thus is a much more potent substance than CIO . 
Even in the frog, where the desensitizing mechanism of 
CIO blockade, amply documented here as well as by Thesleff 
(1955a and b), may explain why certain agents can antagonize 
both CIO and d-Tbc, the behavior of the CIO blockade with re-
gard to anti-ChE presents difficulties. The situation is even 
more obscure in the mammals (cats and, dogs). In these species, 
the ~esensitizing character of CIO blockade is less well docu-
ment,d, and the evidence is mainly indirect. Foldes and his 
associates (cf. for instance, Foldes, 1959) and Zaimis (1959) 
presented data indicating that upon repeated CIO administra-
tion CIO blockade in slow and in fast muscles exhibits aspects 
of competitive blockade, since it is antagonized by anti-ChE 
agents. Actually, methoxyambenonium antagonizes and "reverses 
010 or SOh upon its very first administration to a fast muscle 
of the cat. This obviously suggests that also in the mammals, 
CIO and SCh action and block cannot be purely depolarizing in 
nature, even in th~ early phases of their action. If it were 
so, methoxyambenonium which potentiates the excitatory action 
of CIO and SCh, should subsequently produce increased blockade 
rather than cause "reversal", i.e. conversion of SCh and CIO 
blockade into a prolonged increase of the twitch response. 
It should be stressed that recently Blaber (1960) argued 
that a similar conclusion (cf. Karczmar 1956, 1957 and 1961) 
is not warranted, and attempted to expl~in the anti-CIO 
effects of methoxyambenonium in terms of the original hypothes s 
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of Zaimis (1953). He pointed out that anti-CIO effects of 
methoxyambenonium were obtained upon i.a. administration in the 
oat at lower dose levels tr~n its anti-d-Tbc actions. It was 
-_ .. 
also suggested that higher doses of methoxyambenonium may anta-
gonize C10 by desensitizing the endplate to depolarization. 
However, in the case of the i.v. route in the cat (Karczmar, 
1957) as well as in that of the frog nerve-muscle preparation, 
doses of methoxyambenonium capable of antagonizing CIO and 
d-Tbc are comparable or identical. Furthermore, methoxyam-
benonium can antagonize CIO only at concentrations which are 
considerably below those producing AOh desenSitization and 
concomitant blockade of neuromyal tranSmission (Karczmar, 1957). 
Also, if depolarization were indeed the mechanism underlying 
010 blockade, facilitator,y effects of methoxyambenonium con-
firmed by Blaber (o.c.) should lead to synergism between C10 
and methoxyambenonium, whioh was not the case either in the 
cat or in the frog. 
Even if we assume that action of methoxyambenonium upon 
010 block, in the oat and frog, may depend on the desensitis-
ing charaoter of 010 and SOh block, two problems still remain: 
the explanation of the "reversal" of 010 and SOh action by 
methoxyambenonium, and of the laok of antagonism of SCh and 
010 blook by anti-OhE agents. These two problems will be 
analyzed further after a discussion of the action of the antag-
onists of CIO blook, TEA, NaF, and methoxyambenoni~~. Indeed, 
it may well be that the answer to these problems lies in the 
nature of this aotion. 
o. Meohanism of action of methoxyambenonium, NaP 
and TEA. 
The diffioulty in explaining the action of methoxyam-
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benonium, HaF, and TEA, is that while depolarizers, curare-
mimetics, anti-ChE agents or hydroxymethylammonium compounds 
show some of the characteristics of these three agents, yet 
the combination of properties exhibited by these three com-
pounds is unusual (Table 1). TEA augments e.p.p. but is not 
an anti-ChE agent (Koketsu, 1958), or a depolarizer. In fact, 
TEA blocks ACh depolarization (Koketsu, 1958), and it increases 
ACh desensitization produced by CIO. Also, while TEA produces 
repetitive firing at the e.p., it does so when employed in high 
concentrations, not required for its anti-curare effects and 
for the augmentation of the e.p.p. Thus, TEA is not an anti-
d-Tbc agent by vi~tue of the mechanism: proposed by Riker et ale 
(o.c.). Similarly, methoxyambenonium augments e.p.p., in-
creases the m.e.p.p.'s and sensitizes the e.p. to ACh; yet it 
is a weak anti-ChE (Lands et al., 1955; Karczmar 1957) and at 
concentrations (10-6 to 10-7M) capable of actions at the neuro-
myal junction it does not inhibit AChE (Arnold et ale 1954). 1) 
Also, methoxyambenonium produoes neither depolarization nor 
repetitive firing. NaF also causes AOh sensitization, in-
creases the e.p.p., and antagonizes d-Tbc (Koketsu and Gerard, 
1956), without being a depolarizer, or an anti-ChE agent, or 
an unstabilizer of the nerve terminals. Finally, all these 
three compounds are, in the frog, not only d-Tbc but also 010 
antagonists. 
1) It is of interest that, in the case of the frog isolated 
nerve-muscle preparation, it is possible to compare the con-
centration found irulibitory to AChE in vitro, with the con-
centration effective pharmacologically. Usually, in vitro 
data on anti-ChE action have to be correlated with in ~ 
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data, based on i.v. administration, and expressed in mg./kg.; 
in view of the poor distribution of a bisquaternary compound 
such as methoxyambenonium, such two sets of data are not really 
comparable. Moreover, AChE inhibition, or its absence, upon 
i.v. administration cannot be easily measured, at least mano-
metrically, in the case of a reversible inhibitor such as 
methoxyambenonium (cf. Koelle, 1961a, Karczmar, 1961), and, 
in such experiments, the deduction as to whether or not methoxy 
ambenonium acted as an AChE inhibitor, is difficult to assess. 
The explanation of' these parao.oxical effects of NaF, TEA 
and methoxyambenonium is difficult. It was already suggested 
(Koketsu, 1958) that TEA increases the release of bound ACh 
from the nerve terminals. This would then explain the pheno-
mena observed by Koketsu (o.c.) as well as at present, such 
as the increase and slight prolongation of the e.p.p., com-
pared to the marked e.p.p. prolongation obtained with anti-ChE 
agents; repetitive firing obtained with larger concentrations 
of TEA; anti-d-Tbc action; and the fact that TEA particularly 
effects the e.p.p. and the mechanical response obtained upon 
the first few nerve stimulations. Furthermore, by assuming 
this mechanism, the paradox of a substance which decreases ACh 
sensitivity and yet is an anti-d-Tbo and anti-CIO agent is 
resolved; the amplitude of the e.p.p. and the deblocking action 
would be determined by two antagonistic actions of TEA: ACh 
release and ACh desensitization (Table 1). Finally, the 
present data on CIO antagonism of TEA are consistent both 
with the view of d-Tbo-like action of CIO' and with the ACh-
release mechanism of action of TEA. 
It is more ditficul~ to suggest the mechanism of action 
of methoxyambenonium and of NaF, besides pOinting out certain 
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similarities and dissimilarities of their action. As shown 
by Koketsu (l956) with regard to NeF, and as demonstrated at 
present with regard to methoxyambenonium, neither agent pro-
duces augmentation of the mechanical muscle response to indirect 
stimulation; both sensitize the e.p. to ACh, and both increase 
the e.p.p_; they are not depolarizers or anti-ChE agents. 
While HaP does not prolong ACh depolarization and the e.p.p. 
as much as anti-ChE agents, yet it does so to a certain extent; 
it resembles then in this respect ~EA, while methoxyambenonium 
remains an unique agent in that it produces "augmentation 
without prolongation" both with regard ,to the e.p.p. and to 
ACh depolarization. Yet, Wal resembles methoxyambenonium (and 
also TBl) in still another important respect, as shown at 
present; it is not only en anti-curare but also an anti-CIO 
agent. Koketsu (0.0.) presented some indirect evidenoe that 
NaF does not inorease the release of ACh at the nerve terminal; 
he proposed therefore that "BaP inoreases the affinity of ACh 
for the e.p. membrane and enhances the depolarizing action of 
ACh R (o.c.) by some specific, but hitherto unexplained,aotion. 
In other words, it acts at the postsynaptic site as a sensi-
tizer or facilitator. 
It should be stressed that these terms are used here in 
a sense more specific than that in which Perry (1956) used 
them. Perry (o.c.), speaking of faoilitating compounds, had 
in mind simply oompounds aoting 1n a manner different from 
that of anti-ehB agents, but did not otherwise define their 
aotion. In the light of the present researches, methoxyam-
benonium is a facilitator agent, sensitizing the e.p. to the 
nerve impulse and to ACh; a facilitator can be defined there-
fore as a substanoe that augments, but does not prolong, the 
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e.p.p. and AOh depolarization. This is a rare type of action, 
hitherto not described. 
In view of the similarities of action of NaP and mShoxy-
ambenonium, and since neither is an anti-OhE or AOh-like 
agent, these oompounds may be considered as facilitators. 
It should be however remembered that, since methoxyambenonium 
does not atfect the time course of AOh depolarization and of 
e.p.p. which is somewhat prolonged by NaP, the mechanism of 
action of methoxyambenonium and of Nal cannot be identical. 
In any event, these views of action of metho~ambenonium, 
HaF and TEA, coupled with the concept-y,alization that 010 
blockade depends, like that of d-Tbc,upon ACh desensitization 
or upon com.lJetition with AOh, may constitute a preliminary 
picture of the antagonism between these agents and 010 • 
d. Concluding remarks on CIO-methoxyambenonium 
interplay. 
~he above considerations lead to certain conclusions and 
hypo~heses which can be summarized as follows. In the frog as 
in the oat, 010 blookade must conSist, to an extent at least, 
of desensitizing the e.p. to ACh; this, ooupled with the 
many instances of ACh-sensit1zing actions of methoxyambenoni~ 
at the e.p., shown at present, offers an explanation of its 
effect upon 010 • Otherwise, metho~ambenonium antagonism of 
both CIO and d-Tbc blockade in the cat, and in the frog cannot 
be readily understood. 
As already stated, this does not explain methoxyambenoni 
"reversal tl of 010 and SOh blockade in the cat (Karozmar, 1957 
and 1961). While the final explanation of the "reversal" 
cannot be offered on the basis of these experiments, it may 
be suggested that methoxyambenonium may prevent the desensi-
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tization or competition of 010 postsynaptic aotion (Table 1), 
and synergize with oertain "facilitatory" actions of C10 • 
The possible site and mechanism ot these "taoilitatory" aotions 
of C10 will be discussed subsequently (seotion 2a of this Dis-
cu.ssion). Suffice it to say at present that these aotions 
may be presynaptio and that methoxyambenonium may intensify 
them at that site (Table 1). Methoxyambenonium may have then 
two sites of action, postsynaptio and presynaptic. The f8oci-
litatory poat-synaptio action of methoxyambenonium is amply doc-
umented at present, but its pre-synal~io effeot can be only 
suggested. However, it may be speoulated that both these 
effects are neoessary for the prediction of the 010 "reversal*' 
by methoxyambenonium. 
It may be also suggested that the action of methoxyam-
benonium is kept within "physiological" limits, because its 
effects are not acoompanied by a prolongation of the a.p.p. 
and of AOh depolarization, or by repetitive firing, and because 
methoxyambenonium exhibits depressant properties when employed 
at higher conoentration, suoh as decremental action upon AOh 
depolarization and upon e.p.p. It should be stressed hare 
that also TEA shows biphas10 aotions, and that this may con-
tribute to its anti-010 action in the frog. 
This may have also a bearing on the other problem, pointed 
out above; namely the problem of the lack of antagonism - even 
in the frog - between 010 and anti-OhE agents. Possibly these 
agents lack a built-in safety factor. Also, lack of 010 anta-
gonism by anti-ehE agents may be due, in some kind of a way, 
to the contributory action of 010 depolarization. The depres-
sant effect of anti-OhE agents on the e.p.p_ of 0lO-treated 
neuromyal junctions should be also remembered in this context. 
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More specifically, CIO depolarization, while not playing a 
conspicuous role in the blockade by C10 ' employed alone, may 
be important in the presence of anti-ChE agents. In fact. in-
creased depolarization was noticed at present in the case of 
blocking combinations of CIO and eserine, or CIO and neostig-
mine; anti-ChE agents also produce depolarization, when used 
alone in high concentrations (Douglas and Paton, 1954). Thus, 
ChE inhibitors, by intensifying the depolarizing action of CIO ' 
can cause a pure depolarization blockade, such as suggested 
by Zaimis (o.c.) for CIO alonejor, this component of combined 
action of anti-ChE agents and C10 can contribute to e.p. de-
sensitizing action of C10 -
It appears that TEA, NaF and 
in the frog both d-Tbc and C10 • 
by the similarities in the d-Tbc 
methoxyambenonium antagonize 
This can be partially explained 
and C10 blockade. This antag-
onism must be also based on a special characteristic of TEA, 
HaF and methoxyambenonium, since so many other substances 
cannot antagonize both the C10 and d-Tbc block. This aspect 
of the action of these three agents may be their biphasic 
effect, allowing them to limit undue C10 depolarization, or 
it may depend on a "facilitatory" mechanism or mechanisms 
different from the mechanism of action of anti-ChE's. 
Altogether, this investigation, similar to other recent 
analYSis of the pharmacology of the neuromyal junction (Riker 
et al., 1959; Zaimis, 1959; Karczmar, 1961), indicate multi-
plicity of effects possible at the neuromyal junction. In 
fact, they may serve to emphasize the warning of Bovet (1951) 
that absolute distinction between agents active at the neuro-
myal junction is impossible. Indeed, causally committed terms 
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such as "depolarizers" and "competitors" should be perhaps 
avoided and each neuromyally active agent described in its 
own right and in terms of its characteristic relationships 
at the junction. Whether this state of matter exists be-
cause several sites of action are available within the neuro-
myal junction, or because receptor proteins may exhibit various 
types of responses depending upon the presence of chemical 
agents and on its physiological evironment, cannot be answered 
at present. 
2. Neuromyal actions of ACh and of CIO ' and their 
mechanism. 
One of the main aspects of the action of ACh emerging 
from this research and from that of other investigators, is 
the flexibility of this action. 
Certain similar aspects of action of CIO were brought 
forward in ·~he course of this stud.y. In so far as ACh is con-
cerned, it was found capable of at least three types of action 
at the neuromyal junction, which in turn can be modulated by 
the past history of the junction and by pharmacologic agents. 
To start with, ACh exerted facilitatory actions, probably 
u.nrelated to its depolarizing effect, as well ao blocking 
effects upon the twitch of the indirectly stimulated muscle. 
Secondly, adaptation to blocking concentrations of ACh seemed 
possible, and, the neuromyal junction could be rendered in-
sensitive to blocking concentrations of ACh by means of pre-
treatment with ACh. Finally - and this was brought up also 
in the earlier section of this discussion - neuromyal actions 
of ACh could be increased by agents other than anti-ChEfs 
or releasers of ACh from nerve-end terminals, i.e. by facili-
tators. 
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a. F.aoilitatory and blooking actions of ACh as 
oompared with those of 010. 
Weak concentrations of AOh increased the twitch response 
of the muscle to indirect stimulation. ~his lasted for 5 to 
15 minutes, i.e. over several trains of stimuli. Additionally, 
similar twitch potentiation occurred after a muscle exposed to 
blocking concentrations of ACh was washed out in Ringer; it is 
conceivable that, even after several washes, traces of ACh re-
w.ained at the junction a.nd caused the potentiation. 
It was shown at present that weak concentrations of 010 
also produce facilitation, 010 resembl~ng in this respect AOh. 
However, there seemed to exist some quantitative difference 
between 010 and AOh. 010 facilitation could be much more 
easily obtained than that by ACh. Also, in the case of suitable 
doses, 010 could produce facilitation lasting up to 2 hrs., 
while ACh facilitation was temporary. 
~he facilitatory actions of AOh and of CIO are not easy 
to explain. fwitch potentiation by anti-ChE agents is generally 
considered to be due to repetitive firing (cf. for instanoe, 
Hastuk: and Alexander, 1954; ltarczmar and Fudema, 1957, and 
Karczmar, 1961), i.e. to conversion of single twitches into 
short tetani; similarly, AOh and CIO can produce repetitive 
firing at the height of their depolarization. However, weak 
facilitatory conoentrations of AOh and 010 certainly did not 
produoe significant depolarization. In fact, the fac1litatory 
actions of weak concentrations of AOh and of 010 continued, 
in the case of present experiments, past the period of de-
polarization (figs. 11 and 17); they also could be obtained 
with ooncentrations of ACh and of 010 incapable of significant 
depolarization, as for instance when facilitation was noticed 
56. 
after ACh treatment, following several washes in saline. It 
cannot be ruled out, however, that 010 and AOh could produce, 
employed in concentrations in question, small, essentially not 
measurable, depolarization. Nevertheless, it oannot be easily 
explained why subthreshold depolarization should cause upon 
indireot stimulation increased twitch amplitude. 
It may be speoulated that 010 and AOh faoilitation are 
analogous to post-tetanic faoilitation, and to facilitation 
oocurring in the case of trains of stimuli. Fatt (1959) and 
Dudel and Ruffler (1961) presented indireot evidence that these 
types of faoilitation are due to incr~ased release, upon sti-
mulation, of AOh from the nerve terminals when the terminals 
are sensitized by earlier stimulation; this would be then a 
reoruitment phenomenon, previous activity oausing more nerve 
terminals to become active upon subsequent stimulation. Simi-
larly, AOh and 010 oould produoe increased release of the endo-
genous transmitter from the nerve terminal. It should be added 
that Koelle reoently (1961b) postulated on the basis of in-
direot evidence that, in the course of cholinergio synaptio 
transmission, the stimulus arriving at the synapse oauses 
"direot" release of small quantities of AOh, which then acts 
upon the nerve terminals produoing a more massive release of 
the transmitter. This suggestion is, in faot, related to the 
earlier hypothesis of Masland and Wigton (1940) and of Riker 
and his assooiates (1957, 1959), that certain ammonium ions 
faoilitate and produce anti-d-Tbo action by a presynaptiC 
facilitation at the nerve terminals. It was already suggested 
in an earlier part of this discussion (cf. p. 62) that this 
presynaptio action of CIO may underlie the CIO "reversal" by 
methoxyambenonium. 
57. 
iu.Luther action of ACh that has been studied at present 
i6 the blockade by this age'(lt. This blockade resembled in 
some ways that by 010 but in other respects, differed from 
C10 block. As in the case of CIO the depolarization was 
temporary. Even in the case of strong concentrations of AOh, 
and in continued presence of AOh, the membrane returned spon-
taneously to its normal potontial within 10 to 15 minutes; 
this recovery was faster in the oase of weaker conoentrations. 
Similar data were presented by Thesle!! (1955a and 1955b) and 
Katz and Thesleff (1957). It was pointed out (Fatt, 1959) 
that the neuromya.l jWlCtion, after being depolarized by ACh, 
is not exoitable; altogether, the data suggest that, as in the 
case of C10 ' AOh blockade is not due to depolarization. 
In the case of higher concentrations, ACh blockade was 
essentially irreversible, since it lasted from 2 to 4 hours, 
thus resembling 010 blockade. On the other hand, recovery 
from the blockade could be observed when weaker concentrations 
of AOh were employed. In this case AOh block differed fromthat~ 
ClOt since even weaker concentrations of 010 , "'hich produced 
early f&.oili tation, cau.sed subsequently irreversible, slowly 
progressing blockade. 
It could be that stronger, irreversibly blooking con-
centration of ACh, aa well as late phases of the progressive 
C10 blockade, ma.y be due to changes in the muscle, as indicated 
by the increase in muscle fiber resistance (Kim et al., un-
published). On the other hand, while reversible blocking 
actions of \leaker cOllcentre.tlona of ACh as well as early 
blocking actions of C10 do not depend on depolarization, they 
may differ ill nature. As already stated, C10 blookade may 
be competitive in character; on the other hand, weak concen-
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trations of ACh which cause blockade probably do no"t do so 
competitively. This is suggested by the fact that both neostig-
mine and methoxyambenonium synergized with ACh in the pro-
duction of blockade. It may be thought tlllit neostigmine, which 
augments and prolo~;s ACh depolarization, as shown at present 
and by other investit;ators (cf., for instance, Koketsu and 
Gerard, 1956), san in this way synergize with ACh blookade. 
Thus, AOh in combination with neostigmine may either produce 
pure depolarization blockade, or cause increased desensiti-
zation. The same mechanism may obtain in the case of syner-
gism between C10 or SOh and anti-OhE ~ents, Observed at presen 
in the frog and previously in the cat or dog (Karczmar, 1957 
and 1961; cf. also p. 32). However, methoxyambenonium seems 
even more synergistic with ACh than neostigmine. It syner-
gized with ACh at concentrations lower than equi-effective con-
centrations of neostigmine; yet it is a much weaker anti-ChE 
than neostigmine (Lands et al., 1955), and does not produce 
prolongation of ACh depolarization. Moreover, oonoentrations 
of ACh, oapable of blockade when oombined with subliminal oon-
centrations of methoxyambenonium, did not produce, whether 
used alone or with methoxyambenonium, any measurable depolari-
zation. Thus, the synergism of methoxyambenonium with AOh 
in the produotion of ACh blockade cannot be due to its anti-
OhE or depolarizing action. 
Reoently, Smith (1960) also agreed that ACh blookade 
oannot be due to depolarization; he speculated that AOh and/or 
its hydrolysis products accumulate at the e.p. and oocupy it, 
prev_nting diffusion to the e.p. of added ACh. The blockade 
subliminal concentrations of ACh oombined with subliminal 
by lL 
conoentrations of metboxyambenonium seems to militate against 
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"occupancy" theory of Smith; this ty.pe of block actually 
suggests that ACh is capable of a desensitizing action; this 
action could be, speculatively, due to ACh-induced reoeptor 
change. It can be further speculated that, methoxyambenonium 
can intensify ACh blockade not by inoreasing ACh depolarization 
but by intensifying the postulated desensitizing action of 
AOh at the receptor site. 
On the other hand, this blocking aotion can be curare-
mimetic in nature, dependent upon competition, and thuB re-
semble, in the frog at least, 010 blockade. This may be borne 
out by the fact that after ACh depola~ization is over and the 
blockade ensues, higher concentrations of ACh are still capable 
of producing depolarization. This is also consistent with the 
fact that anti-ChE agents do not depolarize after AOh con-
ditioning, since in a quiescent muscle no free ACh would be 
available for the protective action of the anti-OhE compound. 
Yet, one would expect that "sensitizing" or "facilitatory" 
agents such as methoxyambenonium or NaF, should depolarize 
the refractory e.p. when used in continued presence of ACh, 
which was not the case. Altogether, it may be suggested that 
AOh blockade is not depolarizing in nature, and it may be 
speculated that it is not competitive in charaoter, but de-
pendent upon other hitherto unknown factors. 
b. Additional components of aotion of 010. 
As already discussed, 010 blocks in the frog by desensi-
tizing the e.p. to ACh or perhaps competing at the e.p. with 
ACh. As a competitor t 010 may be displaoed by certain qua-
ternary cations (Riker, 1953), including neostigmine. Com-
petitive character of 010 blockade was also suggested by 
Theslef! (1955a and b) on the basis of his data. Some results 
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obtained here may be explained in a similar fashion. While 
neostigmine in concentrations of lO-5M or higher intensified 
CIO blockade, in weak concentrations it delayed the block 
without decreasing its extent. This result cannot be due to 
anti-ChE action of neostigmine, since this effect would contri-
bute to rather than delay the blockade; it may be due, however, 
to competition between C10 and neostigmine for the receptor 
site. If the CIO blockade is co::npetitive in nature, it d.iffers 
then from the ACh blockade if as speculated above, this blockade 
is not competitive. It must be remembered however that strong 
similarities - some suggested by the Dresent data, 
by other investigators - exist between CIO and ACh. 




when used at low concentrations, &nd both cause blockade which, 
in the frog at least, is independent of their depolarization. 
It is a matter of ~~rther experimentation to ascertain whether 
or not C10 blockade indeed differs from that produced by ACh. 
c. Modulation of ACh action at the neuromyal 
junction. 
The foregOing underlin€d the flexibility of the response 
of the neuromyal junction,exposed to ACh or to C10~to pharma-
cologic agents. The action of ACh, C10 and SCh can be affected 
by competiti~ely acting agents, anti-ChE compounds, unsta-
bilizers of the nerve terminal (Riker et al. 1958), releasers 
of ACh such as TEA,and by sensitizers. More than one type of 
substance may belong to this latter category, since NaF action 
differs in certain aspects from that of methoxyambenonium. 
Another dimension of flexibility of action of ACh and of 
C10 is added by the fact that they can act as facilitators and 
also as blocking agents. The depolarizing action of ACh, just 
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as that of C10 ' seems not to be the basis of their blocking or 
facilitatory action. 
Present experiments deal with changes occurring over long 
time periods. ACh blockade occurs, in oontinued presenoe of 
ACh, after 10 or 15 minutes-long depolarization. Somewhat si-
milar da.ta were presented by Foldes (1959) a.nd Zaimis (1959) Ao!, 
indicating that, employed over extended time periods or upon~' i 
repeated administration, C10 ceases depolarizing and acts as a 
oompetitor of ACh, due presumably to a change in the reoeptor 
protein. Yet, these long duration experiments may also oon-
stitute a wodel of immeasurably faster physiological events 
oocurring at the e.p. If this is the case, the termination of 
action of ACh upon each burst of stimuli way depend not only 
upon ChE's, or upon diffusion, as suggested by Koelle (1959) 
with regard to adrenergic transmitters, but upon a change in 
the reoeptor reaotivity and aocompanying ohange in the mode of 
aotion of ACh. Certain data by Del Castillo and Katz (19540) 
obtained with iontophoretio techniques of ACh applioation may 
suggest the OOOUl~anoe of similar phenomena~ 
The ohange in receptor protein under the impaot of ACh 
seems to be the basis of the spontaneous recovery of the 
neuromyal junction from blooking actions of ACh when the pre-
paration is exposed to continued presence of ACh. Similar 
changes may underlie the development of acute tolerance to 
ACh of the junction whioh oan be demonstrated by "oonditioning" 
of the e.p. to ACh. ACh was not previously considered as 
exhibiting taohyphylaxis, althoUcih recovery from and adaptation 
to high levels of ACh were reported before in the case of 
sympathetic ganglia (Krivoy and Wills, 1956). Adaptation to 
high doses of anti-ChE agents (Karczmar and Koppanyi. 1953; 
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Barnes and Duff, 1953) presumably oonstitute similar phenomena. 
Krivoyand Wills (0.0.) reported that ACh adaptation oocurs irre 
speotive of maintenanoe of eleotronegativity due to the presenoe 
of ACh at the ganglion. At the neuromyal junotion ACh depolari-
zation does not persist in the oontinued presence of ACh; and 
the adaptation to high levels of ACh may be due to the subsi-
dence of depolarization and also to the faot that subsequent 
additions of high levels of ACh lead to a relatively small de-
polarization. In other words, the neuromyal junction adapts 
to a oertain level of ACh and responds not in relation to ab-
solute ooncentrations of ACh, but rath~r to increments or 
gradients of ACh. 
The adaptation meohanism may act most importantly in 
physiological processes of transmission by modulating these 
prooesses~thus making it possible for the transmission to funoti n ~ 
, I. 
in oertain states of hyper-release of ACh and produoing a buffer 
effect in these situations. Suddenly inoreased conoentration 
of ACh at a synapse will still produoe an effect even in con-
tinued presence of ACh derived from previous action; yet this ef 
fect will not be undue or excessive. 
The difference between CIO and ACh with regard to recovery 
from and adaptation to their respeotive blockade is also of 
interest in this context. Indeed, it may be teleologically 
important that the natural transmitter, ACh, exhibits reversi-
bility and tachyphylaxis while the exogenous substanoe, CIO ' 
does not. While these oonsiderations oan be only speoulative 
and the mechanism of pertinent phenomena not available, these 
differenoes between 010 and ACh bear stressing at this time. 
,. Gen!ral conclusion~. 
These investigations, both of actions of suoh pharma-
cologic agents as 010' NaP, TEA and rnethoxyarnbenonium., as well 
as of the oholinergic transmitter ACh, leave us with new facts, 
mechanisms, and with certain speculations. It seems to be well 
substantiated that certain new mechanisms, independent of such 
better known mechanisms as anti-OhE and depolarizing action, 
contribute to the effect of substances capable of deblocking 
the neuromyal junction; among these new mec!~niSmB a specific 
facilitator effect at the e.p. is described here for the 
first time. These mechanisms as well as the non-depolarizing 
aspects of 010 blockade provide the basis for the understanding 
of the relatively few substances capa~le of antagonizing both 
010 and d-Tbc blockade. This antagonism haa heretofore either 
been poorly or not at all explained. 
All this points to a flexibility of processes and multi-
plicity of sites at the neuromyal junction available for drug 
action. Instead of thinking only in terms of depolarizing 
and competitive and anti-OhE actions, we can also think of 
releasers of AOh such as ~EA, as well as of facilitatory agents 
such as NaF or metho~ambenonium. Finally, even the action 
of AOh at the neuromyal junction may be speculatively resolved 
into tacilitatory and blocking components. Furthermore, some 
of the data here may suggest that neither of these aOtions 
depends on the usual transmitter action of ACh, i.e. upon its 
depolarizing property. This, plus the demonstrated recovery 
and adaptation processes occurring at the neuromyal junction 
with regard to the action of ACh, provides not only for the 
flexibility of cholinergic transmission, but may be considered 
as important in modulating cholinergic transmission and pre-
serving its function in special phySiological conditions. 
F. Summax:y 
I. Objectives and Methods 
1. Tetraethylammonium (TEA), NaF, and methoxyambenoni 
urn were studied with regard to their actions at the neuromyal 
Junction, as well as with regard to their interaction with 
C10 and d-tubocurarine (d-Tbc). Moreover, actions of CIO 
and of acetylcholine (ACh) at the neuromyal junction were 
com~red. 
2. The purpose of the study was: 1) to explain the 
antagonism of both d-Tbc and 010 by methoxyambenonium which is 
diffioult to understand in the light ~f present theories of the 
blocking action of d-Tbo and of 0lOi 2) to study the effects 
of newer anti-d-Tbo agents, TEA and NaF, upon 010 blockade; 
3) to compare these effects with those of anticholinesterase 
agents; and 4) to explo~e whether AOh and CIO exert other than 
depolarizing aotion at the neuromyal junction. 
3. The study was carried out employing the mechanical 
twitch response to indirect stimulation of the frog sartorius 
muscle and measuring membrane phenomena such as endplate po-
tential (e.p.p.), endplate and muscle membrane polarity, and 
miniature endplate potentials (m.e.p.p.'s). 
4. Mechanical muscle response was studied by means 
of a force transducer and a polygraph. External and internal 
micro-electrodes and oscillographio reoordings were employed 
for the study of the membrane phenomena. 
II. DrMa Effeots on the Meohanical Response of the Musole 
to !ndirect Stimulation. 
A. Eff,ot of methoxyambenonium, ambenonium •. and Na' on 
muscle twitoh. 
1. When supramaximal stimulation was used, methoxy-
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ambenonium did not increase the twitch amplitude at concen-
tration of 5 x 10-7 to lO-5M. Higher concentrations caused 
slowly developing blockade which was comulete within 30 to 
50 minutes. 
2. \,Ij'hen submaximal stimulation was employed, methoxy-
ambenonium increased the twitch amplitude 20% to 40% above the 
control level. 
3. Ambenonium produced some blockade at 5 x lO-6M 
concentrationj higher concentrations caused a more complete 
blockade. 
4. Employed at concentratio~8 of 0.3 to 1 x lO-3M, 
TEA produced increase of muscle twitch amplitude on the first 
stimulus of each train of stimuli both for supra- or sub-maxi-
mal stimulation. 
B. Effects of methoxyambenonium, TEA and NaF uEPn C10 
and d-Tbc blockade. 
1. Methoxyambenonium produced partial restoration of 
transmission blocked by C10 in the case of supramaximal sti-
mUlation of intact nerve. More consistent antagonism between 
CIO and methoxyambenonium (3 x 10-6 to 1.5 x 10-4M) occurred 
with divided nerve or sub maximal stimulation. 
2. TEA (3 x 10-4 to 10-3M) was more effective against 
C10 than methoxyambenonium_ 
3. For submaximal stimUlation the muscle twitch de-
pressed by C10 was augmented by TEA to an amplitude height 
above that of controls obtained prior to CIO treatment. The 
anti-C10 effect of TEA was especially pronounced in the case 
of the first few responses, a.nd twitch amplitude subsequently 
devreased. 
4. NaF exhibited antagonistic action to the C10 
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blookade of submaximal stimulation, but not supramaximal sti-
mulation. 
5. Anti-ChE agents, ambenonium (10-7 to 10-5M), neo-
stigmine (10-6 to 5 x 10-5M) and eserine (0.5 to 1.0 x lO-5M), 
used after the onset of CIO block, had no antagonistic effect 
upon C10 blockade. 
6. ~~en neostigmine was eml~yed in weak concentrations 
simultaneously with 010, the onset of 010 blookade was delayed; 
eserine did not exhibit this aotion. 
7. A oombination of eserine (5 x 10-6M) and of methoxy 
ambenonium oaused partial restoration;of transmission blocked 
by 010 , even with supramaximal indirect stimulation. 
s. ~iethoxyambenonium (1.0 to 2.0 x lO-6M) produoed 
within a few minutes restoration of transmission blocked by 
d-Tbo. iaster deblooking or intensification or original d-Tbo 
blookade was notioed with stronger oonoentrations. 
9. TEA in weaker ooncentration (3 to 5 x 10-4M) pro-
duoed restoration of transmission. With higher ooncentration 
of 'fEA, the mechanioal responses were initially augmented and 
then gradually depressed. 
o. Effects of AOh and of 010 on Muscle Twitoh. 
1. Generally AOh had depressant actions upon neuro-
myal transmission. After washing out the AOh, the twitch am-
plitude was inoreased above the control level. Faoilitation 
sometimes ooourred also with weaker ooncentrations (lO-6M) of 
AOh-following suoh a sequence. 
2. 010 in weak concentrations (10-5 to lO-~) exhi-
bited ~ronounced and prolonged faoi11tatory effect on the trans 
mission. "Treppe" wa.s alwa.ys noticed. 
-6 3. With weaker concentrations of AOh (5 x 10 to 
lO-5M) which produced relatively small depression of trans-
mission, spontaneous recovery could be observed. This did 
not occur with higher concentrations of AOI1, or with both 
low and high blocking concentrations of CIO ; in these in-
stances, persistent blockade was noticed. 
4. It was demonstrated that neuromuscular trans-
mission can be conditioned to even higher concentrations of 
ACh, or to AOh with neostigmine. 
5. Subliminal concentrations of methoxyambenonium 
(lO-7M) produced marked blockade when.added to subliminal con-
centrations of ACh (lO-~). 
6. Adaptation or recovery phenomena were never notice 
in the case of 010 blockade. lV-en with concentra.tions of CIO 
causing initial facilitation (5 x 10-6 to 6 x lO-5M), subse-
quunt blockade was progressive in nature. 
III. Effects at the Endplate and on the MU,scle Membrane. 
A. Interaction of HaF, TEA and methoxyambenonium with 
d-Tbc and .910• 
1. It was determined that neither methoxyambenanium, 
NaF, nor TEA had any effect on the resting potential of the 
muscle fiber membrane or on the action potential of single 
fibers. 
2. Metho1yambenonium increased the amplitude of 
m.e.p.p.'s but not their frequency. Eserine had no such 
action. 
3. Methoxyambenoniwn, NaIl' and TEA all increased the 
e.p.p., whether the transmission was blOcked by d-Tbc or by 
C10 • 
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4. Anticholinesterase agents markedly prolonged the 
e.p.p.. In the case of 0lO-blocked transmission, they frequent-
ly decreased the e.p.p. amplitude. 
5. TEA and NaF prolonged e.p.p. slightly. Methoxy-
ambenonium produced e.p.p. "augmentation without prolongation". 
Methoxyambenonium is considered, therefore, a facilitator agent. 
6. In high concentrations (10-4M), TEA produced re-
petitive firing whether the transmission was blocked with 010 
or with d-Tbc. Methoxyambenonium was devoid of this action. 
7. AOh depolarization of the endplate was increased 
and prolonged by anti-cholinesterase agents. Methoxyambenonium 
increased AOh depolarization without prolonging it at low 
(10-6 to 10-5M) concentrations and decreased it at higher con-
centrations (10-5 to 10-4M). 
8. TEA, in all effective concentrations (10-5 to 10-4 
M), decreased AOh depolarization. 
B. Me9hanism of the an]agonism between 910 , and TiA 
~d me~hoXlambenonium. 
1. C10 depolarized the a.p., but the blockade of 
transmission bega.n after the peak depolarization was reached; 
the block to indirect stimulation increased and persisted 
after the der)olarization was over. This is in confirmation 
of earlier data of Thesleff (19558. and b). 
2. 010 desensitized the endplate to AOh, which again 
confirms the data of Thesleff. This effect could be reversed 
by methoxyambenonium (10-6 to 10-5M), but ACh desensitization 
was intensified by a.ll effective concentrations of TEA. 
;. C10 and d-Tbc synergized in blocking the trans-
mission and decreasing the e.p.p. 
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4. Both methoxyambenonium (5 x 10-5 to 10-6M) and T 
(0.1 to 0.5 x 10-4M) increased the e.p.p. obtained in the pre-
sence of d-Tbc and CIO • 
o. Etf!cys of ACh. 
1. ACh depolarization, similarly to that by C10 ' 
runs a time course which is not parallel with AOh blookade of 
neuromyal transmission. 
2. After AOh depolarization oeased, and before neuro 
myal transmission was restored, the endplate was depolarized 
to a small extent by higher oonoentrations of ACh. This con-
firms earlier data of Del Castillo and Katz (1954a). 
3. The endplate, desensitized by ACh, could not be 
depolarized again by eserine or methoxyambenonium in oontinued 
presence of AOh. 
4. The highest degree of depolarization of desensi-
tized endplate was obtained by employment of AOh combined with 
weak (10-6M) concentration of methoxyambenonium. 
IV. Conclusions and hypotheses. 
1. One of the reasons why NaF. TEA, and methoxyam-
benonium can antagonize both C10 and d-Tbc block of the frog 
nerve-muscle .preparation must be t.bat ClOt like d-Tbo, blocks 
mainly by desensitizing the endplate to ACh. 
2. NaF and methoxyambenonium are faoilitatory com-
pounds, distinct from anticholinesterase agents. TEA anta-
gonizes d-Tbc and 010 possibly by releasing ACh trom motor 
nerve terminals. 
3. Speculation as to why NaF, TEA, and methoxyambeno 
nium (but not anticholinesterase agents) antagonize 010' must 
relate to the fact that anticholinesteraaea do not increase 
e.p •.• of the endplate blocked by CIO • This may be due to 
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intensification of the depolarizing action of CIO by anti-
cholinesterases. 
4. CIO "reversal" by methoxyambenonium may be ex-
plained on the basis of two actions of the latter: A) the 
facilitating postsynaptic a.ction, demonstrated here which an-
tagonizes CIO desensitization of the endplate, and B) inten-
sifying action of me"thoxyarubenonium on "the i:Jresynaptic com-
ponent of CIO action, leading to the increase of twitch ampli-
tude. 
5. Flexibility of the neuromyal transmission is well 
expressed by diversified actions and mechanisms of action of 
agents studied here. Even CIO and ACh actions at the neuro-
myal junction differ. 
6. Another dimension of flexibility of the neuro-
myal junction is ex~ressed by the fact that neuromyal trans-
mission can be conditioned to high concentrations of ACh, and 
may recover from ACh blockade. 
7. Physiological significa.nce of these findings 
is discussed. 
CONTROL 15 min. after 
WIN 8078, 7xI0-' 
I ! I I " , " , ! I 
. 
13:07 
30 min. a Iter 
WIN8078 
Fig. 1: Blocking effect of high concentrationLl of methoxyam-
benonium (WIN 8078, 7 x 10-5ri1) upon neuromyal transmission. 
Frog sartorius muscle stimulated indirectly. Cf. Viethods for 




20 ml n. after 
C,O~ 5x10-i 
14:07 
1 min. after 
WIN 8078,5xI0-' 
Fig. 2: Twitch response of frog sartorius to stimulation of 
of undivided nerve. Rare example, in these conditions, of 
restoration by methoxyambenonium (WIN 8078, 5 x 10-5M) of 
neuromyal transmission blocked. by C10 (5 x 10-6M). Other 
indications as in fig. 1. 
• • tH! lUI U ~ . ~ tJ,UJJ,lll. 
CONTROL CONTROL AFTER 35 MIN 3MIN 45 MIN 
C-IO 2XI0-15 
__ 
NERVE DIVISION WIN 8078 5XI0 
Fig. 3: Antagonism between CIO (2 x 10-5M) and methoxyambenon-
ium (WIN 8078, 5 x 10-6M). stimulation of divided nerve. 
Other explanations as in fig. 1. 
r.:---
TIME I: 10 
eONTROL 
,: 32 
20 min. after 
C 10 7.!5X 10-1 M 
,: 37 
Smln .• ft,r 
T.E. A. O.Om M 
Fig. 4: Partial antagonism between TEA and C10 (7.5 x lO-5M). 
Responses to supramaximal nerve stimulation. Note particularly 
the increased amplitude of the first muscle response after TEA. 













Fig. 5: Antagonism between TEA, 5 x 10-3M and C10, 5 x 10-6M. 
Submaximal stimulation of the nerve. Note ineffectiveness of 
eserine, 5 x 10-6M, administered prior to TEA. Cf. also fig. 1. 















DELAY OF ONSET OF C-IO BLOCKADE 
BY PROSTI8MINE 
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CONTROL 10 MIN 
\ -
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CONTROL 5 MIN 10MIN 
-I 
C-IO 2XI0 .e 
. PR08TII .. IN. eXlo 
Fig. 7: Upper row: blockade of neuromyal transmission by CIO ' 2 x 10-51'1[. After several washes in Ringer, the twitch re-
turned to control levels (lower row, first record). Subse-
quently, CIO ' 2 x 10-
51'1[, was added simultaneously with prostig-
mine, 5 x 10-61'1[. Onset of blockade Ivas delayed (compare top 
and bottom rows). 
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WI N 8078 
50 MIN 
RINGER 
Fig. 8: Partial restoration of neuromyal transmission, 
blocked_by C10' 5 x 10-5M, by methoxyambenonium (WIN 8078), 
5 x 10-6Ivl, preceded by eserine, 5 x 10-6M. Supramaximal 
I stimulation of undivided nerve (cf. also fig. 1). 









22 min.af", d-Tbc 5 min.afte' 
. WIN 8078,IXIO-~. 
lig. 9; Antagonism between d-tuboourarige (d-Tbc, 3 x 10-6M) 
and methoxyambenonium (WIN 8078, 5 x 10- M). Supramax1mal 
stimulation. Ct. also fig. 1. 
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Fig. 10: Antagonism between d-tuboeurarine Cd-Tbe, 3 x 10-6M) 
and TEA, 5 x 10-4M. Other explanations as in fig. 9. 











4SMIN. OMIN RINeERS 
Fig. 11: Facilitation of neuromyal transmiss~on by weak 
concentrations of acetylcholine (ACh, 7 x 10- M). Note also 
that, after facilitation ceased and blockade supervened 
(after 45 minutes of treatment), the wash in Ringer led to 
secondary facilitation. Supramaximal stimulation. 






40 MIN. 60 MIN./ 70 MIN. 90 MIN. AFTER 
10 MIN. 
IN RINGER 
Fig. 12: Recovery of neuromyal transmission after blockade by 
acetylcholine. Consecutive records, at time intervals indi-
cated, of the twitch amplitude of indirectly stimulated sar-
torius muscle in acetylcholine (ACh, 5 x lO-6M). Fresh solution 


















Fig. 13: Plot of spontaneous recovery of neuromyal trans-
mission from partial blockade induced by acetylcholine (ACh, 
7 x lO-6Mj crosses and dashed line), and by acetylcholine-
neostigmine combination (ACh, 2 x lO-8M with NST, 1 x lO-6Mj 
circles and continuous line). Abscissae: time in minutes; 
ordinate: twitch amplitude in percent of the control twitch. 
The experiment dealing with recovery from ACh is different 
from the one illustrated in fig. 12. 
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Fig. 14: Spontaneous recovery of neuromval transmission 
recorded after partial blockade due to simultaneous em-
ployment of acetylcholine (ACh, 2 x lO-8M) and neostigmine 
(NST, lO-6M). Indirect, supramaximal stimulation. 
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••••• 10 MIN. '5 MIN. 20 MIN. 25 MIN. 30 MIN. 
Fig. 15: "Adaptation" of neuromyal transmission to high, 
blocking concentrations of acetylcholine. Upper row: first 
treatment with acetylcholine (ACh, 1 x 10-5M). After blockade 
was rec~tded, the preparation was washed. Subsequently, ACh 
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Fig. 16: Plot of the time course of an experiment leading 
to adaptation to ACh. Abscissa: time in minutes. Ordinate: 
twitch amplitude in percent of control twitch. The preparation 
was first exposed for 25 minutes to 2 x lO-5M ACh solution 
(crosses and dashed line); after wash in Ringer, the prepara-
tion was exposed, successively, to 5 x lO-6M, 1 x lO-5M, 
and 2 x 105M ACh solutions (circles and continuous line). 
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Fig. 17: Prolonged facilitation of neuromyal transmission by 
CIO' 4 x lO-6M• Notice repeated "treppe" phenomenon. Last 
set of responses indicates the effect of a 20 minutes saline 
wast. 
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Fig. 18: Blockade of neuromyal transmission by CIO (2 x 10-5M) 
and the recovery after wash in Ringer. Note that the "treppe" 
occurred during the control period as well as following the 
wash, but disappeared when CIO blockade was present. Supra-
maximal stimulation. 
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Fig. 19: The three rows of this figure illustrate three 
exposures of a frog nerve-muscle preparation to C10 ' lO-5M. 
The exposures were separated by three wash periods. Notice 
that the blocking effect of C10 increased on each subsequent 
exposure. Supramaximal stimulation. 
CONTROL -6 ESERINE 5XI0 
-6 
WIN 8078 5XI0 
Fig. 20: Effect of methoxyambenonium (WIN 8078, 5 x 10-6M) 
upon the amplitude of the miniature endplate potentials 
(m.e.p.p. 's). Notice that eserine had$r~teffect, and that 
the amplitude rather than frequency of m.e.p.p.'s was in-
creased by methoxyambenonium. Each record shows from 6 to 
8 sweeps (rate of the sweep 2ms/cm; approximate time interval 
between sweeps 0.1-0.2 sec.) on the oscilloscope screen. For 
further details on techniques, cf. Methods. 
CONTROL E.P.P. reduced by 
-8 
CURARE 1.5X 10M 
-6 
2 min. ofter WIN 8078 I X 10M 
Fig. 21: Augmentator~ (facilitatory) effect of methoxyambeno-
nium (WIN 8078, 10-6M) upon endplate potential (a.p.p.) of 
curarized frog nerve-muscle preparation. Lower and upper 
tracings, A.C. and D.C. recordings, respectively_ Shock 
artefact visible in each tracing. Cf. also Methods. 
Fi~. 22: Effect of TEA, lO-4M, upon endplate potential (e.p.p.) 
of nerve-muscle preparation. Transmission blocked by ClOt 
5 x 10-5M (upper record). Four super1mposable e.p.p.'s re-
corded. Lower record, two tracings 5 minutes after TEA. 
First tracing illustrates prolongation of e.p.p. by TEA. The 
very next sweep (after 0.1 sec.) shows spikes and repetitive 
firing. Cf. also Methods and Text. 
CONTROL E.P.P. 
C-IO 5XIO-7 




" MIN AFTER 
WIN 8078 ~XIO-S 
:15 MIN AFTER 
ESERINE 3X10- S 
20 MIN AFTER 
ESERINE 3XI0-6 
Fig. 2~: The effects of va.rious chemical agents upon the e.p. 
p. Molar concentrations throughout. Top-row: the effect of 
methoxyambenonium (WIN 8078) upon the e.p.p. after the blockade 
of transmission by C10. Observe that single spike seemed to 
have been induced by methoxyambenonium; note also that methoxy-
ambenonium caused "augmentation without prolongation" of the 
e.p.p. Middle-~: the effect of physostigmine (eserine) upon 
the e.p.p. of the curarized preparation. Note the conspicuous 
prolongation of the e.p.p. by physostigmine. Bottom-row: the 
effect of physostigmine upon a.p •. p. produced by 010- Note that 
the control a.p.p. is at a threshold level of depola.rization 
(t~le bot3inning of a spL;"e is observable), and that eserine 
~roduced e.p.p. reduotio~. 
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Fig. 24: Effect of C10 upon the endplate and neuromyal trans-
mission. Upper row, ~witch amplitude and time in minutes. 
Lower row: external electrodes recording at the e.p. (ordinate); 
abscissae: time in minutes. Time scale identical in both re-
cords. The preparation was first exposed to acetylcholine (ACh, 
5 x lO-5M) and depolarization recorded (fu11 circles and con-
tinous line). After wash, C 0 (5 x lO-5r-r) depolarization 
(lower row; empty circles an~ discontinuous line) and blockade 
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Fig. 25: Acetylcholine (ACh, 5 x 10-5M) depolarization 
after and before C10 ' 5 x 10-5M. External electrodes re-
cording. First, depolarization due to ACh alone was re-
corded (empty circles). After wash, and exposure of the 
preparation to C10 (5 minutes), ACh depolarization was di-
minished (triangles). After wash, sensitivity to ACh re-
turned to normal (not shown) and the preparation was exposed 
fir~t to C10' and then to A?h and TEA, 10-4M. ACh depolari-
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Fig. 26: The effect of rnethoxyarnbenonium (WIN 8078) upon 
depolarization by acetylcholine (ACh) , diminished by CIO. 
Firstly, CIO (5 x 10-5M) depolarization was measured (triangles 
and continuous line). After wash in Ringer, essentially simi-
lar depolarization was obtained by CIO, 5 x 10-5M, and WIN 
8078, 10-5M, employed simultaneously (crosses and dashed line). 
After appropriate wash in Ringer, ACh (5 x 10-5M) depolarizatio 
was measured (semi-empty circles and continuous line); followi 
wash in Ringer and treatment with CIO (5 x 10-5M), ACh depolari 
zation was diminished (empty circles and continuous line), 
finally, after one more wash, combined treatment with CIO, 
ACh and WIN 8078 (5 x 10-5M in each case) caused increased 
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tig. 21: Biphasic effect of methoxyambenonium (WIN 8078) 
upon acetylcholine (ACh) depolarization, The preparation 
was exposed first to lOh alone, then to ACh and weak concentrati~n of WiN 8078, and, finally, to AOh and strong 
concentration of WIN 8078. The preparation was washed in 
Ringer between treatments. External electrodes. Other 
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Fig. 28: Augmentation and prolongation of acetylcholine 
(ACh) depolarization by eserine. The neuromyal preparation 
was first exposed to ACh alone, and then, after appropriate 
wash in Ringer, to ACh and eserine. External electrodes 
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Fig. 29: Lack of effect of TEA upon acetylcholine (ACh) de-
polarization reduced by CIO treatment. CIO depolarization 
was first measured with (dots and thin line) and without 
(full circles and dashed line) TEA; TEA seemed to increase 
somewhat CIO depolarization. Subsequently, ACh depolarization 
was measured with (full circles and continuous line, lower 
part of the i~lustration) and Iii thout (full circles and thick 
line) CIO' Addition of TEA did not increase ACh depolarization 
in presence of CIO (full circles and thin line, lower part of 
the figure). Appropriate washes after each treatment. Exter-
nal electrodes recording. 
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Fig. 30: Effect of acetylcholine (ACh) upon the endplate and 
neuromyal transmission. Upper record, recording of muscle 
twitch (indirect st5mulation). Lower record, depolarization due to ACh (5 x 10- M), measured with external electrodes. 
Identical sc~les (minutes) for the measurement of depolari-
zation and of the muscle twitch. Note that partial ACh 
blockade developed after the peak depolarization, and per-
sisted for some time after depolarization was over (15-20 
minutes). Spontaneous recovery of transmission (25 - 30 











O~ IL'ESERINE 5XI0 















Fig. 31: Desensitization of the endplate by acetylcholine 
(ACh, 5 x 10-5M). After ACh depolarization (circles and con-
tinuous line) was over, eserine (5 x 10-6M) had no depolarizing 
action in continued presence of ACh, while strong concentration 
of ACh, and particularly, combined treatment with weak con-
centrations of ACh (5 x 10-6M) and of methoxyambenonium (WIN 
8078, 5 x 10-61\11) were effective (full circles and continuous 
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Fig. 32: Desensitization of the endplate by acetylcholine 
(ACh, 5 x 10-6M). After ACh depolarization was over, addition 
of 10 times more concentrated ACh solution caused some de-
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